Tag | Content |
---|---|
Uniprot ID | P11362; A8K6T9; A8K8V5; C1KBH8; P17049; Q02063; Q02065; Q14306; Q14307; Q53H63; Q59H40; Q5BJG2; Q8N685; Q9UD50; Q9UDF0; Q9UDF1; Q9UDF2; |
Entrez ID | 2260 |
Genbank protein ID | AAA35835.1; CAA40404.1; AAH91494.1; CAA68679.1; AAA35838.1; ACO38646.1; AAS79322.1; AAA35836.1; AAA35958.1; CAA40402.1; BAF84443.1; CAA40403.1; AAA35839.1; AAA35837.1; CAA36101.1; AAA75007.1; CAA40401.1; BAD96438.1; CAA37015.1; CAA47375.1; AAH15035.1; AAA35840.1; BAD92156.1; BAF85159.1; CAA40400.1; AAA35959.1; AAA35960.1; AAH18128.1; |
Genbank nucleotide ID | NM_015850.3; NM_001174065.1; NM_023110.2; NM_023105.2; NM_001174066.1; NM_001174067.1; NM_001174064.1; NM_001174063.1; NM_023106.2; |
Ensembl protein ID | ENSP00000380280; ENSP00000400162; ENSP00000393312; ENSP00000433163; ENSP00000380302; ENSP00000432972; ENSP00000380297; ENSP00000337247; ENSP00000348537; ENSP00000327229; |
Ensembl nucleotide ID | ENSG00000077782 |
Gene name | Fibroblast growth factor receptor 1 |
Gene symbol | FGFR1 |
Organism | Homo sapiens |
NCBI taxa ID | 9606 |
Cleft type | CL/P |
Developmental stage | |
Data sources | Manually collected |
Reference | 17366557; 28232668; 26199944; |
Functional description | Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation. |
Sequence | MWSWKCLLFW AVLVTATLCT ARPSPTLPEQ AQPWGAPVEV ESFLVHPGDL LQLRCRLRDD 60 VQSINWLRDG VQLAESNRTR ITGEEVEVQD SVPADSGLYA CVTSSPSGSD TTYFSVNVSD 120 ALPSSEDDDD DDDSSSEEKE TDNTKPNRMP VAPYWTSPEK MEKKLHAVPA AKTVKFKCPS 180 SGTPNPTLRW LKNGKEFKPD HRIGGYKVRY ATWSIIMDSV VPSDKGNYTC IVENEYGSIN 240 HTYQLDVVER SPHRPILQAG LPANKTVALG SNVEFMCKVY SDPQPHIQWL KHIEVNGSKI 300 GPDNLPYVQI LKTAGVNTTD KEMEVLHLRN VSFEDAGEYT CLAGNSIGLS HHSAWLTVLE 360 ALEERPAVMT SPLYLEIIIY CTGAFLISCM VGSVIVYKMK SGTKKSDFHS QMAVHKLAKS 420 IPLRRQVTVS ADSSASMNSG VLLVRPSRLS SSGTPMLAGV SEYELPEDPR WELPRDRLVL 480 GKPLGEGCFG QVVLAEAIGL DKDKPNRVTK VAVKMLKSDA TEKDLSDLIS EMEMMKMIGK 540 HKNIINLLGA CTQDGPLYVI VEYASKGNLR EYLQARRPPG LEYCYNPSHN PEEQLSSKDL 600 VSCAYQVARG MEYLASKKCI HRDLAARNVL VTEDNVMKIA DFGLARDIHH IDYYKKTTNG 660 RLPVKWMAPE ALFDRIYTHQ SDVWSFGVLL WEIFTLGGSP YPGVPVEELF KLLKEGHRMD 720 KPSNCTNELY MMMRDCWHAV PSQRPTFKQL VEDLDRIVAL TSNQEYLDLS MPLDQYSPSF 780 PDTRSSTCSS GEDSVFSHEP LPEEPCLPRH PAQLANGGLK RR 822 |
Abbreviation :
CLO : cleft lip only. CPO : cleft palate only.
CLP : cleft lip and palate. CL/P : cleft lip with/without cleft palate.
For humans: CL/P, CLO, CPO, and CLP. For mice: CLO, CLP, and CPO.
Relation | Gene symbol | Entrez ID | UniProt ID | Cleft type | Developmental stage | Species | Evidence | Details |
---|---|---|---|---|---|---|---|---|
1:1 ortholog | FGFR1 | 281768 | A4IFL5 | Bos taurus | Prediction | More>> | ||
1:1 ortholog | FGFR1 | 100856477 | A0A5F4CQJ1 | Canis lupus familiaris | Prediction | More>> | ||
1:1 ortholog | FGFR1 | A0A452E6I8 | Capra hircus | Prediction | More>> | |||
1:1 ortholog | FGFR1 | 2260 | P11362 | CL/P | Homo sapiens | Publication | More>> | |
1:1 ortholog | Fgfr1 | 14182 | P16092 | CPO | E14.5, E16.5 | Mus musculus | Publication | More>> |
1:1 ortholog | FGFR1 | A0A2I3RMA9 | Pan troglodytes | Prediction | More>> | |||
1:1 ortholog | Fgfr1 | F1LM54 | Rattus norvegicus | Prediction | More>> | |||
1:1 ortholog | fgfr1b | F1Q5T3 | Danio rerio | Prediction | More>> |
Gene symbol | Significant Variants/SNPS | Methods | PubMed ID |
---|---|---|---|
FGFR1 | rs13317A>G | GWAS | 28232668 |
FGFR1 | c.1868A>G; p.Asp623Gly (heterozygous) | Sanger sequencing | 31512363 |
FGFR1 | c.874C>G; p.His292Asp (heterozygous) | Clinical exome sequencing and Sanger sequencing | 32871658 |
FGFR1 | c.358C>T; p.R120C (heterozygous) | Next-Generation Sequencing; Sanger sequencing | 26199944 |
FGFR1 | c.776G>A; p.G259E (heterozygous) | Next-Generation Sequencing; Sanger sequencing | 26199944 |
FGFR1 | rs7829058G>C | Genotyping | 21462296 |
FGFR1 | rs674354C>T | Genotyping | 21462296 |
FGFR1 | rs13317 | Genotyping | 17366557 |
ID | Variant | Type | Disease | Chromosome\Coordinate | Evidence |
---|---|---|---|---|---|
rs1554594114 | p.Trp2Ter | stop gained | - | NC_000008.11:g.38457441C>T | - |
RCV000662312 | p.Trp2Ter | nonsense | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38457441C>T | ClinVar |
COSM6180979 | p.Ser3Ile | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38457439C>A | NCI-TCGA Cosmic |
rs1241452278 | p.Ser3Cys | missense variant | - | NC_000008.11:g.38457440T>A | gnomAD |
rs751651299 | p.Ser3Asn | missense variant | - | NC_000008.11:g.38457439C>T | ExAC,TOPMed,gnomAD |
rs760884357 | p.Trp4Cys | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38457435C>G | UniProt,dbSNP |
VAR_074012 | p.Trp4Cys | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38457435C>G | UniProt |
rs760884357 | p.Trp4Cys | missense variant | - | NC_000008.11:g.38457435C>G | gnomAD |
rs532741632 | p.Leu7Arg | missense variant | - | NC_000008.11:g.38457427A>C | 1000Genomes,ExAC,TOPMed,gnomAD |
rs1202687392 | p.Leu7Phe | missense variant | - | NC_000008.11:g.38457428G>A | gnomAD |
rs1259538191 | p.Leu8Phe | missense variant | - | NC_000008.11:g.38457425G>A | gnomAD |
rs750602076 | p.Phe9Ile | missense variant | - | NC_000008.11:g.38457422A>T | ExAC,gnomAD |
COSM4858059 | p.Trp10Cys | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38457417C>A | NCI-TCGA Cosmic |
rs1285368969 | p.Trp10Arg | missense variant | - | NC_000008.11:g.38457419A>G | TOPMed,gnomAD |
rs762020019 | p.Ala11Val | missense variant | - | NC_000008.11:g.38457415G>A | ExAC,gnomAD |
rs765703437 | p.Ala11Thr | missense variant | - | NC_000008.11:g.38457416C>T | ExAC,gnomAD |
rs764533580 | p.Leu13Pro | missense variant | - | NC_000008.11:g.38457409A>G | ExAC,gnomAD |
RCV000711646 | p.Thr15Ter | frameshift | - | NC_000008.11:g.38457405_38457411dup | ClinVar |
rs200596591 | p.Ala16Val | missense variant | - | NC_000008.11:g.38457400G>A | ExAC,gnomAD |
rs771549051 | p.Leu18Phe | missense variant | - | NC_000008.11:g.38457395G>A | ExAC,gnomAD |
rs759243486 | p.Cys19Ser | missense variant | - | NC_000008.11:g.38457391C>G | ExAC,gnomAD |
COSM3648925 | p.Thr20Ile | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38457388G>A | NCI-TCGA Cosmic |
rs1383262590 | p.Ala21Thr | missense variant | - | NC_000008.11:g.38457386C>T | gnomAD |
rs17175750 | p.Arg22Ser | missense variant | - | NC_000008.11:g.38457381C>G | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
rs148343099 | p.Arg22Gly | missense variant | - | NC_000008.11:g.38457383T>C | ESP,ExAC,TOPMed |
rs143341876 | p.Pro23Leu | missense variant | - | NC_000008.11:g.38457379G>A | ESP,ExAC,TOPMed,gnomAD |
rs149206728 | p.Pro25Leu | missense variant | - | NC_000008.11:g.38457373G>A | ESP,TOPMed,gnomAD |
rs1230569367 | p.Leu27Phe | missense variant | - | NC_000008.11:g.38457366C>A | TOPMed,gnomAD |
rs1204612499 | p.Pro28Ser | missense variant | - | NC_000008.11:g.38457365G>A | gnomAD |
RCV000493590 | p.Pro28Leu | missense variant | - | NC_000008.11:g.38457364G>A | ClinVar |
rs145434725 | p.Pro28Leu | missense variant | - | NC_000008.11:g.38457364G>A | ESP,ExAC,TOPMed,gnomAD |
rs758551875 | p.Glu29Gly | missense variant | - | NC_000008.11:g.38457361T>C | ExAC,gnomAD |
rs1240973335 | p.Glu29Asp | missense variant | - | NC_000008.11:g.38457360T>G | gnomAD |
rs1371683958 | p.Pro33Ser | missense variant | - | NC_000008.11:g.38429943G>A | gnomAD |
rs773442656 | p.Gly35Arg | missense variant | - | NC_000008.11:g.38429937C>T | ExAC,TOPMed,gnomAD |
rs1424869652 | p.Ala36Val | missense variant | - | NC_000008.11:g.38429933G>A | gnomAD |
rs377555354 | p.Val38Met | missense variant | - | NC_000008.11:g.38429928C>T | ESP,ExAC,TOPMed,gnomAD |
rs1164001578 | p.Glu39Lys | missense variant | - | NC_000008.11:g.38429925C>T | gnomAD |
rs1181847676 | p.Val40Met | missense variant | - | NC_000008.11:g.38429922C>T | gnomAD |
rs938545315 | p.Glu41Val | missense variant | - | NC_000008.11:g.38429918T>A | gnomAD |
rs1460882520 | p.Glu41Lys | missense variant | - | NC_000008.11:g.38429919C>T | gnomAD |
rs1200752017 | p.Ser42Pro | missense variant | - | NC_000008.11:g.38429916A>G | gnomAD |
RCV000489554 | p.Phe43Cys | missense variant | - | NC_000008.11:g.38429912A>C | ClinVar |
rs1085307493 | p.Phe43Cys | missense variant | - | NC_000008.11:g.38429912A>C | TOPMed |
rs769061510 | p.His46Tyr | missense variant | - | NC_000008.11:g.38429904G>A | ExAC,TOPMed,gnomAD |
rs747480026 | p.Pro47Leu | missense variant | - | NC_000008.11:g.38429900G>A | ExAC,TOPMed,gnomAD |
RCV000017691 | p.Gly48Ser | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38429898C>T | ClinVar |
rs121909640 | p.Gly48Ser | missense variant | - | NC_000008.11:g.38429898C>T | - |
rs121909640 | p.Gly48Ser | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38429898C>T | UniProt,dbSNP |
VAR_030968 | p.Gly48Ser | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38429898C>T | UniProt |
rs1381400802 | p.Asp49Glu | missense variant | - | NC_000008.11:g.38429893G>T | TOPMed,gnomAD |
rs145315779 | p.Arg54His | missense variant | - | NC_000008.11:g.38429879C>T | 1000Genomes,ExAC,gnomAD |
RCV000552834 | p.Arg54Cys | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38429880G>A | ClinVar |
rs778531708 | p.Arg54Cys | missense variant | - | NC_000008.11:g.38429880G>A | ExAC,gnomAD |
rs763858257 | p.Arg56Gln | missense variant | - | NC_000008.11:g.38429873C>T | ExAC,gnomAD |
rs1034848904 | p.Arg56Trp | missense variant | - | NC_000008.11:g.38429874G>A | TOPMed |
rs1301127877 | p.Leu57Met | missense variant | - | NC_000008.11:g.38429871G>T | TOPMed |
rs1162148796 | p.Arg58Trp | missense variant | - | NC_000008.11:g.38429868G>A | gnomAD |
rs200116660 | p.Arg58Gln | missense variant | - | NC_000008.11:g.38429867C>T | 1000Genomes,ExAC,TOPMed,gnomAD |
rs150042321 | p.Asp59Val | missense variant | - | NC_000008.11:g.38429864T>A | 1000Genomes,ExAC,gnomAD |
rs150042321 | p.Asp59Gly | missense variant | - | NC_000008.11:g.38429864T>C | 1000Genomes,ExAC,gnomAD |
NCI-TCGA novel | p.Asp60Gly | missense variant | - | NC_000008.11:g.38429861T>C | NCI-TCGA |
rs762089291 | p.Val61Met | missense variant | - | NC_000008.11:g.38429859C>T | ExAC,TOPMed,gnomAD |
rs776846726 | p.Val61Ala | missense variant | - | NC_000008.11:g.38429858A>G | ExAC,TOPMed,gnomAD |
rs1195026291 | p.Gln62His | missense variant | - | NC_000008.11:g.38429854C>G | gnomAD |
COSM1099654 | p.Ile64Phe | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38429850T>A | NCI-TCGA Cosmic |
rs768919123 | p.Asn65His | missense variant | - | NC_000008.11:g.38429847T>G | ExAC,gnomAD |
rs375271913 | p.Asn65Ser | missense variant | - | NC_000008.11:g.38429846T>C | ESP,ExAC,TOPMed,gnomAD |
rs1358163666 | p.Arg68Gln | missense variant | - | NC_000008.11:g.38429837C>T | gnomAD |
rs775895631 | p.Arg68Trp | missense variant | - | NC_000008.11:g.38429838G>A | ExAC,gnomAD |
rs1240511730 | p.Asp69Gly | missense variant | - | NC_000008.11:g.38429834T>C | gnomAD |
rs1309311395 | p.Asp69Asn | missense variant | - | NC_000008.11:g.38429835C>T | TOPMed,gnomAD |
rs140254426 | p.Gly70Trp | missense variant | - | NC_000008.11:g.38429832C>A | ESP,ExAC,TOPMed,gnomAD |
rs140254426 | p.Gly70Arg | missense variant | - | NC_000008.11:g.38429832C>T | ESP,ExAC,TOPMed,gnomAD |
rs140254426 | p.Gly70Arg | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38429832C>T | UniProt,dbSNP |
VAR_072993 | p.Gly70Arg | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38429832C>T | UniProt |
RCV000323081 | p.Val71Leu | missense variant | - | NC_000008.11:g.38429829C>A | ClinVar |
rs561300213 | p.Val71Leu | missense variant | - | NC_000008.11:g.38429829C>A | 1000Genomes,ExAC,TOPMed,gnomAD |
rs1554570813 | p.Gln72Ter | stop gained | - | NC_000008.11:g.38429826G>A | - |
RCV000593963 | p.Gln72Ter | nonsense | - | NC_000008.11:g.38429826G>A | ClinVar |
rs143241978 | p.Ala74Val | missense variant | - | NC_000008.11:g.38429819G>A | ESP,ExAC,TOPMed,gnomAD |
rs1445020368 | p.Glu75Lys | missense variant | - | NC_000008.11:g.38429817C>T | TOPMed |
rs777425797 | p.Ser76Gly | missense variant | - | NC_000008.11:g.38429814T>C | ExAC,TOPMed,gnomAD |
rs755882398 | p.Ser76Thr | missense variant | - | NC_000008.11:g.38429813C>G | ExAC,gnomAD |
rs752495999 | p.Asn77Ser | missense variant | - | NC_000008.11:g.38429810T>C | ExAC,gnomAD |
rs767195580 | p.Asn77Lys | missense variant | - | NC_000008.11:g.38429809G>C | UniProt,dbSNP |
VAR_030969 | p.Asn77Lys | missense variant | - | NC_000008.11:g.38429809G>C | UniProt |
rs767195580 | p.Asn77Lys | missense variant | - | NC_000008.11:g.38429809G>C | ExAC,TOPMed,gnomAD |
rs1554570706 | p.Arg78Cys | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38429808G>A | UniProt,dbSNP |
VAR_030970 | p.Arg78Cys | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38429808G>A | UniProt |
rs754968374 | p.Arg78His | missense variant | - | NC_000008.11:g.38429807C>T | ExAC,TOPMed,gnomAD |
RCV000704507 | p.Arg78Cys | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38429808G>A | ClinVar |
rs1306185959 | p.Thr79Ala | missense variant | - | NC_000008.11:g.38429805T>C | gnomAD |
rs201055054 | p.Arg80His | missense variant | - | NC_000008.11:g.38429801C>T | 1000Genomes,ExAC,TOPMed,gnomAD |
rs751494167 | p.Arg80Cys | missense variant | - | NC_000008.11:g.38429802G>A | ExAC,TOPMed,gnomAD |
rs201574031 | p.Ile81Val | missense variant | - | NC_000008.11:g.38429799T>C | ESP,ExAC,TOPMed,gnomAD |
rs760780809 | p.Thr82Ile | missense variant | - | NC_000008.11:g.38429795G>A | ExAC,gnomAD |
rs760780809 | p.Thr82Arg | missense variant | - | NC_000008.11:g.38429795G>C | ExAC,gnomAD |
rs775969080 | p.Gly83Glu | missense variant | - | NC_000008.11:g.38429792C>T | ExAC,gnomAD |
rs1404670039 | p.Val86Met | missense variant | - | NC_000008.11:g.38429784C>T | gnomAD |
rs139867599 | p.Val88Leu | missense variant | - | NC_000008.11:g.38429778C>A | ESP,ExAC,TOPMed,gnomAD |
NCI-TCGA novel | p.Gln89His | missense variant | - | NC_000008.11:g.38429773C>A | NCI-TCGA |
rs773938208 | p.Gln89Arg | missense variant | - | NC_000008.11:g.38429774T>C | ExAC,TOPMed,gnomAD |
rs770577710 | p.Asp90Tyr | missense variant | - | NC_000008.11:g.38429772C>A | ExAC,gnomAD |
rs1486438088 | p.Ser91Pro | missense variant | - | NC_000008.11:g.38429769A>G | TOPMed |
rs755828990 | p.Val92Met | missense variant | - | NC_000008.11:g.38429766C>T | ExAC,TOPMed,gnomAD |
rs372511659 | p.Pro93Ser | missense variant | - | NC_000008.11:g.38429763G>A | ESP,ExAC,TOPMed,gnomAD |
rs751512391 | p.Ala94Thr | missense variant | - | NC_000008.11:g.38429760C>T | ExAC,TOPMed,gnomAD |
rs751512391 | p.Ala94Ser | missense variant | - | NC_000008.11:g.38429760C>A | ExAC,TOPMed,gnomAD |
rs150973404 | p.Ala94Glu | missense variant | - | NC_000008.11:g.38429759G>T | ESP,gnomAD |
VAR_074013 | p.Ser96Cys | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
rs1260404537 | p.Gly97Ser | missense variant | - | NC_000008.11:g.38429751C>T | gnomAD |
VAR_017885 | p.Gly97Asp | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
rs1203704169 | p.Leu98Ile | missense variant | - | NC_000008.11:g.38429748G>T | gnomAD |
rs727505373 | p.Tyr99Cys | missense variant | - | NC_000008.11:g.38429744T>C | gnomAD |
RCV000156961 | p.Tyr99Cys | missense variant | Hypogonadotropic hypogonadism 7 with or without anosmia (HH7) | NC_000008.11:g.38429744T>C | ClinVar |
RCV000156962 | p.Tyr99Cys | missense variant | Delayed puberty | NC_000008.11:g.38429744T>C | ClinVar |
rs142638017 | p.Cys101Trp | missense variant | - | NC_000008.11:g.38429737G>C | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
VAR_030971 | p.Cys101Phe | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
RCV000625740 | p.Val102Ile | missense variant | Hartsfield syndrome | NC_000008.11:g.38429736C>T | ClinVar |
RCV000644523 | p.Val102Ile | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38429736C>T | ClinVar |
rs55642501 | p.Val102Ile | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38429736C>T | UniProt,dbSNP |
VAR_030972 | p.Val102Ile | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38429736C>T | UniProt |
rs55642501 | p.Val102Ile | missense variant | - | NC_000008.11:g.38429736C>T | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
COSM3834685 | p.Ser104Arg | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38429730T>G | NCI-TCGA Cosmic |
rs752855457 | p.Ser104Asn | missense variant | - | NC_000008.11:g.38429729C>T | ExAC,gnomAD |
rs1325974579 | p.Ser105Asn | missense variant | - | NC_000008.11:g.38429726C>T | gnomAD |
rs1404198159 | p.Pro106Leu | missense variant | - | NC_000008.11:g.38429723G>A | gnomAD |
rs1454598352 | p.Pro106Ser | missense variant | - | NC_000008.11:g.38429724G>A | gnomAD |
rs140382957 | p.Ser107Leu | missense variant | - | NC_000008.11:g.38429720G>A | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
RCV000546208 | p.Ser107Leu | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38429720G>A | ClinVar |
rs1419947824 | p.Gly108Ser | missense variant | - | NC_000008.11:g.38429718C>T | gnomAD |
rs1169626921 | p.Gly108Ala | missense variant | - | NC_000008.11:g.38429717C>G | gnomAD |
rs1474403980 | p.Ser109Asn | missense variant | - | NC_000008.11:g.38429714C>T | gnomAD |
rs1372382432 | p.Asp110Asn | missense variant | - | NC_000008.11:g.38429712C>T | gnomAD |
rs1183685814 | p.Asp110Gly | missense variant | - | NC_000008.11:g.38429711T>C | gnomAD |
rs775020833 | p.Thr111Ile | missense variant | - | NC_000008.11:g.38429708G>A | ExAC,TOPMed,gnomAD |
COSM3699074 | p.Tyr113Cys | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38429702T>C | NCI-TCGA Cosmic |
rs1275520154 | p.Tyr113Ter | stop gained | - | NC_000008.11:g.38429701G>T | gnomAD |
rs1227903216 | p.Phe114Ile | missense variant | - | NC_000008.11:g.38429700A>T | TOPMed |
NCI-TCGA novel | p.Ser115Phe | missense variant | - | NC_000008.11:g.38429696G>A | NCI-TCGA |
rs747842199 | p.Val116Ile | missense variant | - | NC_000008.11:g.38429694C>T | ExAC,gnomAD |
rs780765366 | p.Asn117Ser | missense variant | - | NC_000008.11:g.38429690T>C | ExAC,TOPMed,gnomAD |
rs1447767109 | p.Val118Ile | missense variant | - | NC_000008.11:g.38429688C>T | gnomAD |
NCI-TCGA novel | p.Ser119Ala | missense variant | - | NC_000008.11:g.38429685A>C | NCI-TCGA |
rs1354935534 | p.Ser119Leu | missense variant | - | NC_000008.11:g.38429684G>A | gnomAD |
rs755042837 | p.Asp120Gly | missense variant | - | NC_000008.11:g.38428435T>C | ExAC,gnomAD |
rs1307187624 | p.Ala121Val | missense variant | - | NC_000008.11:g.38428432G>A | TOPMed,gnomAD |
COSM3648909 | p.Pro123Ser | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38428427G>A | NCI-TCGA Cosmic |
rs1169416110 | p.Pro123Leu | missense variant | - | NC_000008.11:g.38428426G>A | TOPMed |
rs1201443010 | p.Ser124Phe | missense variant | - | NC_000008.11:g.38428423G>A | gnomAD |
NCI-TCGA novel | p.Ser124Cys | missense variant | - | NC_000008.11:g.38428423G>C | NCI-TCGA |
RCV000418895 | p.Ser125Leu | missense variant | Neoplasm | NC_000008.11:g.38428420G>A | ClinVar |
rs121913473 | p.Ser125Leu | missense variant | - | NC_000008.11:g.38428420G>A | ExAC,TOPMed,gnomAD |
rs121913473 | p.Ser125Leu | missense variant | - | NC_000008.11:g.38428420G>A | UniProt,dbSNP |
VAR_042201 | p.Ser125Leu | missense variant | - | NC_000008.11:g.38428420G>A | UniProt |
rs758823379 | p.Glu126Asp | missense variant | - | NC_000008.11:g.38428416C>A | ExAC,TOPMed,gnomAD |
rs1425815338 | p.Asp127Val | missense variant | - | NC_000008.11:g.38428414T>A | gnomAD |
rs750795714 | p.Asp127Glu | missense variant | - | NC_000008.11:g.38428413A>C | ExAC,gnomAD |
rs77734798 | p.Asp128Val | missense variant | - | NC_000008.11:g.38428411T>A | gnomAD |
rs77734798 | p.Asp128Gly | missense variant | - | NC_000008.11:g.38428411T>C | gnomAD |
rs77734798 | p.Asp128Ala | missense variant | - | NC_000008.11:g.38428411T>G | gnomAD |
RCV000521203 | p.Asp129Ala | missense variant | - | NC_000008.11:g.38428408T>G | ClinVar |
rs765615419 | p.Asp129Ala | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38428408T>G | UniProt,dbSNP |
VAR_030973 | p.Asp129Ala | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38428408T>G | UniProt |
rs765615419 | p.Asp129Ala | missense variant | - | NC_000008.11:g.38428408T>G | ExAC,TOPMed,gnomAD |
rs765615419 | p.Asp129Gly | missense variant | - | NC_000008.11:g.38428408T>C | ExAC,TOPMed,gnomAD |
rs757823218 | p.Asp130Asn | missense variant | - | NC_000008.11:g.38428406C>T | ExAC,gnomAD |
rs1161536828 | p.Asp130Val | missense variant | - | NC_000008.11:g.38428405T>A | gnomAD |
rs562958780 | p.Asp132His | missense variant | - | NC_000008.11:g.38428400C>G | ExAC,TOPMed,gnomAD |
rs562958780 | p.Asp132Asn | missense variant | - | NC_000008.11:g.38428400C>T | ExAC,TOPMed,gnomAD |
rs562958780 | p.Asp132Tyr | missense variant | - | NC_000008.11:g.38428400C>A | ExAC,TOPMed,gnomAD |
rs1248111718 | p.Asp133His | missense variant | - | NC_000008.11:g.38428397C>G | TOPMed,gnomAD |
rs1213683426 | p.Asp133Glu | missense variant | - | NC_000008.11:g.38428395G>T | TOPMed |
rs1248111718 | p.Asp133Asn | missense variant | - | NC_000008.11:g.38428397C>T | TOPMed,gnomAD |
rs1181137021 | p.Ser134Ala | missense variant | - | NC_000008.11:g.38428394A>C | gnomAD |
rs760116083 | p.Ser134Phe | missense variant | - | NC_000008.11:g.38428393G>A | ExAC,gnomAD |
rs760116083 | p.Ser134Tyr | missense variant | - | NC_000008.11:g.38428393G>T | ExAC,gnomAD |
rs775228360 | p.Ser135Thr | missense variant | - | NC_000008.11:g.38428391A>T | ExAC,TOPMed,gnomAD |
rs767034103 | p.Ser135Phe | missense variant | - | NC_000008.11:g.38428390G>A | ExAC,TOPMed,gnomAD |
COSM5169532 | p.Glu137Asp | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38428383C>A | NCI-TCGA Cosmic |
rs1189578264 | p.Glu138Gly | missense variant | - | NC_000008.11:g.38428381T>C | TOPMed |
RCV000289001 | p.Lys139Glu | missense variant | Hypogonadism with anosmia (KS) | NC_000008.11:g.38428379T>C | ClinVar |
RCV000347374 | p.Lys139Glu | missense variant | Osteoglophonic dysplasia (OGD) | NC_000008.11:g.38428379T>C | ClinVar |
RCV000386920 | p.Lys139Glu | missense variant | - | NC_000008.11:g.38428379T>C | ClinVar |
RCV000391006 | p.Lys139Glu | missense variant | Nonsyndromic Trigonocephaly | NC_000008.11:g.38428379T>C | ClinVar |
RCV000290110 | p.Lys139Glu | missense variant | Pfeiffer syndrome (ACS5) | NC_000008.11:g.38428379T>C | ClinVar |
rs201054877 | p.Lys139Glu | missense variant | - | NC_000008.11:g.38428379T>C | ExAC,TOPMed,gnomAD |
rs770745123 | p.Lys139Arg | missense variant | - | NC_000008.11:g.38428378T>C | ExAC,gnomAD |
rs200482627 | p.Thr141Arg | missense variant | - | NC_000008.11:g.38428372G>C | ESP,ExAC,TOPMed,gnomAD |
rs1315551279 | p.Thr141Ala | missense variant | - | NC_000008.11:g.38428373T>C | TOPMed,gnomAD |
COSM4771179 | p.Asp142Glu | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38428368A>T | NCI-TCGA Cosmic |
rs768880947 | p.Thr144Asn | missense variant | - | NC_000008.11:g.38428363G>T | ExAC,gnomAD |
rs773225979 | p.Thr144Ala | missense variant | - | NC_000008.11:g.38428364T>C | ExAC,gnomAD |
RCV000585124 | p.Arg148His | missense variant | - | NC_000008.11:g.38428351C>T | ClinVar |
rs515726222 | p.Arg148His | missense variant | - | NC_000008.11:g.38428351C>T | ExAC,TOPMed,gnomAD |
rs780153672 | p.Arg148Cys | missense variant | - | NC_000008.11:g.38428352G>A | ExAC,TOPMed,gnomAD |
rs751194353 | p.Pro150His | missense variant | - | NC_000008.11:g.38428093G>T | ExAC |
rs746094709 | p.Pro150Ser | missense variant | - | NC_000008.11:g.38428346G>A | ExAC,gnomAD |
rs762665767 | p.Val151Ile | missense variant | - | NC_000008.11:g.38428091C>T | ExAC,TOPMed,gnomAD |
rs1033377277 | p.Ala152Ser | missense variant | - | NC_000008.11:g.38428088C>A | gnomAD |
rs1033377277 | p.Ala152Thr | missense variant | - | NC_000008.11:g.38428088C>T | gnomAD |
RCV000625700 | p.Ala152Thr | missense variant | Hartsfield syndrome | NC_000008.11:g.38428088C>T | ClinVar |
RCV000301620 | p.Trp155Arg | missense variant | - | NC_000008.11:g.38428079A>G | ClinVar |
rs886042254 | p.Trp155Arg | missense variant | - | NC_000008.11:g.38428079A>G | - |
rs761727709 | p.Pro158Leu | missense variant | - | NC_000008.11:g.38428069G>A | ExAC,gnomAD |
rs776567959 | p.Glu159Gly | missense variant | - | NC_000008.11:g.38428066T>C | ExAC,gnomAD |
NCI-TCGA novel | p.Lys164Arg | missense variant | - | NC_000008.11:g.38428051T>C | NCI-TCGA |
RCV000056314 | p.Leu165Ser | missense variant | Hartsfield syndrome | NC_000008.11:g.38428048A>G | ClinVar |
rs397515481 | p.Leu165Ser | missense variant | Hartsfield syndrome (HRTFDS) | NC_000008.11:g.38428048A>G | UniProt,dbSNP |
VAR_070851 | p.Leu165Ser | missense variant | Hartsfield syndrome (HRTFDS) | NC_000008.11:g.38428048A>G | UniProt |
rs397515481 | p.Leu165Ser | missense variant | Hartsfield syndrome (hrtfds) | NC_000008.11:g.38428048A>G | - |
rs928639974 | p.Leu165Val | missense variant | - | NC_000008.11:g.38428049A>C | TOPMed |
rs772054562 | p.His166Tyr | missense variant | - | NC_000008.11:g.38428046G>A | ExAC,gnomAD |
RCV000030929 | p.Ala167Ser | missense variant | Hypogonadotropic hypogonadism 2 with anosmia | NC_000008.11:g.38428043C>A | ClinVar |
rs121909630 | p.Ala167Ser | missense variant | - | NC_000008.11:g.38428043C>A | - |
rs121909630 | p.Ala167Ser | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38428043C>A | UniProt,dbSNP |
VAR_017887 | p.Ala167Ser | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38428043C>A | UniProt |
rs1413642890 | p.Pro169Leu | missense variant | - | NC_000008.11:g.38428036G>A | gnomAD |
NCI-TCGA novel | p.Ala170Ser | missense variant | - | NC_000008.11:g.38428034C>A | NCI-TCGA |
VAR_072995 | p.Val174Ala | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
rs1172942794 | p.Lys177Glu | missense variant | - | NC_000008.11:g.38428013T>C | TOPMed |
VAR_030974 | p.Cys178Ser | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
rs1183624798 | p.Ser181Gly | missense variant | - | NC_000008.11:g.38428001T>C | gnomAD |
NCI-TCGA novel | p.Leu188Gln | missense variant | - | NC_000008.11:g.38427979A>T | NCI-TCGA |
rs778166317 | p.Arg189His | missense variant | - | NC_000008.11:g.38427976C>T | ExAC,TOPMed,gnomAD |
RCV000200962 | p.Arg189Cys | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38427977G>A | ClinVar |
rs863223331 | p.Arg189Cys | missense variant | - | NC_000008.11:g.38427977G>A | - |
rs1554567027 | p.Trp190Leu | missense variant | - | NC_000008.11:g.38427973C>A | - |
RCV000516914 | p.Trp190Leu | missense variant | - | NC_000008.11:g.38427973C>A | ClinVar |
RCV000208879 | p.Leu191Ser | missense variant | Hartsfield syndrome | NC_000008.11:g.38427970A>G | ClinVar |
rs869025669 | p.Leu191Ser | missense variant | - | NC_000008.11:g.38427970A>G | - |
COSM1456942 | p.Asn193LysPheSerTerUnk | frameshift | Variant assessed as Somatic; HIGH impact. | NC_000008.11:g.38427963_38427964insT | NCI-TCGA Cosmic |
rs1348010838 | p.Asn193Asp | missense variant | - | NC_000008.11:g.38427965T>C | gnomAD |
rs770139002 | p.Lys195Arg | missense variant | - | NC_000008.11:g.38427958T>C | ExAC,TOPMed,gnomAD |
NCI-TCGA novel | p.Glu196Ter | stop gained | - | NC_000008.11:g.38427956C>A | NCI-TCGA |
NCI-TCGA novel | p.Phe197Leu | missense variant | - | NC_000008.11:g.38427951G>C | NCI-TCGA |
rs1260057072 | p.Pro199Thr | missense variant | - | NC_000008.11:g.38427947G>T | gnomAD |
rs1240845932 | p.Asp200Tyr | missense variant | - | NC_000008.11:g.38427944C>A | gnomAD |
RCV000662313 | p.Arg209Cys | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38426242G>A | ClinVar |
NCI-TCGA novel | p.Arg209His | missense variant | - | NC_000008.11:g.38426241C>T | NCI-TCGA |
rs1554564353 | p.Arg209Cys | missense variant | - | NC_000008.11:g.38426242G>A | - |
COSM1133830 | p.Ala211Val | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38426235G>A | NCI-TCGA Cosmic |
rs17851623 | p.Trp213Gly | missense variant | - | NC_000008.11:g.38426230A>C | - |
rs17851623 | p.Trp213Gly | missense variant | - | NC_000008.11:g.38426230A>C | UniProt,dbSNP |
VAR_030975 | p.Trp213Gly | missense variant | - | NC_000008.11:g.38426230A>C | UniProt |
rs763771933 | p.Ile216Val | missense variant | - | NC_000008.11:g.38426221T>C | ExAC,TOPMed,gnomAD |
COSM1456937 | p.Asp218Asn | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38426215C>T | NCI-TCGA Cosmic |
VAR_030976 | p.Asp224His | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
rs1246231808 | p.Gly226Ala | missense variant | - | NC_000008.11:g.38426190C>G | gnomAD |
rs762961614 | p.Asn227Ser | missense variant | - | NC_000008.11:g.38426187T>C | ExAC,gnomAD |
VAR_069289 | p.Tyr228Asp | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
rs765537201 | p.Val232Leu | missense variant | - | NC_000008.11:g.38426173C>A | ExAC |
rs121909635 | p.Gly237Ser | missense variant | - | NC_000008.11:g.38426158C>T | - |
rs121909635 | p.Gly237Ser | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38426158C>T | UniProt,dbSNP |
VAR_030978 | p.Gly237Ser | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38426158C>T | UniProt |
RCV000017684 | p.Gly237Ser | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38426158C>T | ClinVar |
VAR_030977 | p.Gly237Asp | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
rs761920009 | p.Ser238Asn | missense variant | - | NC_000008.11:g.38426154C>T | ExAC,gnomAD |
rs777114323 | p.Ile239Val | missense variant | - | NC_000008.11:g.38426152T>C | ExAC,gnomAD |
VAR_069290 | p.Ile239Thr | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
rs768900681 | p.Asn240Ser | missense variant | - | NC_000008.11:g.38426148T>C | ExAC |
NCI-TCGA novel | p.Asn240Tyr | missense variant | - | NC_000008.11:g.38426149T>A | NCI-TCGA |
VAR_030979 | p.Leu245Pro | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
rs771734626 | p.Asp246Gly | missense variant | - | NC_000008.11:g.38426130T>C | ExAC,gnomAD |
RCV000379458 | p.Val248Met | missense variant | - | NC_000008.11:g.38426125C>T | ClinVar |
rs186746130 | p.Val248Met | missense variant | - | NC_000008.11:g.38426125C>T | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
rs1402339930 | p.Glu249Asp | missense variant | - | NC_000008.11:g.38424698C>A | TOPMed,gnomAD |
rs1402339930 | p.Glu249Asp | missense variant | - | NC_000008.11:g.38424698C>G | TOPMed,gnomAD |
COSM3900045 | p.Arg250Trp | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38424697G>A | NCI-TCGA Cosmic |
RCV000223933 | p.Arg250Pro | missense variant | - | NC_000008.11:g.38424696C>G | ClinVar |
rs121909645 | p.Arg250Gln | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38424696C>T | UniProt,dbSNP |
VAR_069291 | p.Arg250Gln | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38424696C>T | UniProt |
RCV000030940 | p.Arg250Gln | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38424696C>T | ClinVar |
rs121909645 | p.Arg250Pro | missense variant | - | NC_000008.11:g.38424696C>G | - |
VAR_030980 | p.Arg250Trp | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
rs1064793120 | p.Ser251Phe | missense variant | - | NC_000008.11:g.38424693G>A | - |
RCV000481168 | p.Ser251Phe | missense variant | - | NC_000008.11:g.38424693G>A | ClinVar |
rs121913472 | p.Pro252Thr | missense variant | - | NC_000008.11:g.38424691G>T | UniProt,dbSNP |
VAR_042202 | p.Pro252Thr | missense variant | - | NC_000008.11:g.38424691G>T | UniProt |
rs121913472 | p.Pro252Thr | missense variant | - | NC_000008.11:g.38424691G>T | - |
rs121909627 | p.Pro252Arg | missense variant | Pfeiffer syndrome (PS) | NC_000008.11:g.38424690G>C | UniProt,dbSNP |
VAR_004111 | p.Pro252Arg | missense variant | Pfeiffer syndrome (PS) | NC_000008.11:g.38424690G>C | UniProt |
rs121909627 | p.Pro252Arg | missense variant | Jackson-weiss syndrome (jws) | NC_000008.11:g.38424690G>C | ExAC,TOPMed,gnomAD |
RCV000644520 | p.Pro252Arg | missense variant | Pfeiffer syndrome (ACS5) | NC_000008.11:g.38424690G>C | ClinVar |
RCV000017670 | p.Pro252Arg | missense variant | Jackson-Weiss syndrome (JWS) | NC_000008.11:g.38424690G>C | ClinVar |
RCV000017669 | p.Pro252Arg | missense variant | Pfeiffer syndrome (ACS5) | NC_000008.11:g.38424690G>C | ClinVar |
RCV000436130 | p.Pro252Thr | missense variant | Neoplasm | NC_000008.11:g.38424691G>T | ClinVar |
NCI-TCGA novel | p.Arg254Gln | missense variant | - | NC_000008.11:g.38424684C>T | NCI-TCGA |
VAR_030981 | p.Arg254Gln | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
NCI-TCGA novel | p.Ala259Val | missense variant | - | NC_000008.11:g.38424669G>A | NCI-TCGA |
rs1196509455 | p.Pro262Leu | missense variant | - | NC_000008.11:g.38424660G>A | TOPMed |
RCV000268656 | p.Ala263Thr | missense variant | - | NC_000008.11:g.38424658C>T | ClinVar |
COSM1137869 | p.Ala263Ser | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38424658C>A | NCI-TCGA Cosmic |
RCV000275517 | p.Ala263Thr | missense variant | Hypogonadism with anosmia (KS) | NC_000008.11:g.38424658C>T | ClinVar |
RCV000366723 | p.Ala263Thr | missense variant | Osteoglophonic dysplasia (OGD) | NC_000008.11:g.38424658C>T | ClinVar |
RCV000309645 | p.Ala263Thr | missense variant | Pfeiffer syndrome (ACS5) | NC_000008.11:g.38424658C>T | ClinVar |
rs747978107 | p.Ala263Thr | missense variant | - | NC_000008.11:g.38424658C>T | ExAC,gnomAD |
RCV000327189 | p.Ala263Thr | missense variant | Nonsyndromic Trigonocephaly | NC_000008.11:g.38424658C>T | ClinVar |
rs515726223 | p.Asn264His | missense variant | - | NC_000008.11:g.38424655T>G | - |
RCV000119058 | p.Asn264His | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38424655T>G | ClinVar |
rs754968289 | p.Lys265Gln | missense variant | - | NC_000008.11:g.38424652T>G | ExAC,gnomAD |
NCI-TCGA novel | p.Ala268Thr | missense variant | - | NC_000008.11:g.38424643C>T | NCI-TCGA |
VAR_030982 | p.Gly270Asp | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
rs1131691929 | p.Val273Met | missense variant | - | NC_000008.11:g.38424628C>T | gnomAD |
rs1131691929 | p.Val273Met | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38424628C>T | UniProt,dbSNP |
VAR_030983 | p.Val273Met | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38424628C>T | UniProt |
RCV000492969 | p.Val273Met | missense variant | - | NC_000008.11:g.38424628C>T | ClinVar |
rs727505369 | p.Glu274Gly | missense variant | - | NC_000008.11:g.38424624T>C | - |
RCV000156951 | p.Glu274Gly | missense variant | Hypogonadotropic hypogonadism 7 with or without anosmia (HH7) | NC_000008.11:g.38424624T>C | ClinVar |
RCV000156952 | p.Glu274Gly | missense variant | Delayed puberty | NC_000008.11:g.38424624T>C | ClinVar |
rs1443012936 | p.Glu274Lys | missense variant | - | NC_000008.11:g.38424625C>T | TOPMed |
RCV000518169 | p.Glu274Ter | frameshift | - | NC_000008.11:g.38424624del | ClinVar |
rs1314424523 | p.Phe275Leu | missense variant | - | NC_000008.11:g.38424620G>T | gnomAD |
rs1394711867 | p.Met276Val | missense variant | - | NC_000008.11:g.38424619T>C | gnomAD |
VAR_017888 | p.Cys277Tyr | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
RCV000483935 | p.Val279Gly | missense variant | - | NC_000008.11:g.38424609A>C | ClinVar |
rs1064793121 | p.Val279Gly | missense variant | - | NC_000008.11:g.38424609A>C | - |
COSM3900033 | p.Ser281Asn | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38424603C>T | NCI-TCGA Cosmic |
VAR_030985 | p.Pro283Arg | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
NCI-TCGA novel | p.Gln284His | missense variant | - | NC_000008.11:g.38424593C>A | NCI-TCGA |
COSM2960503 | p.Pro285Ser | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38424592G>A | NCI-TCGA Cosmic |
rs779380483 | p.Pro285Leu | missense variant | - | NC_000008.11:g.38424591G>A | gnomAD |
rs767977802 | p.Ile293Val | missense variant | - | NC_000008.11:g.38424568T>C | ExAC,gnomAD |
RCV000608240 | p.Glu294Lys | missense variant | Holoprosencephaly sequence (HPE) | NC_000008.11:g.38424565C>T | ClinVar |
rs528376963 | p.Glu294Lys | missense variant | - | NC_000008.11:g.38424565C>T | 1000Genomes,ExAC,gnomAD |
rs1396391500 | p.Lys299Gln | missense variant | - | NC_000008.11:g.38424550T>G | TOPMed |
rs121909633 | p.Ile300Thr | missense variant | Trigonocephaly 1 (trigno1) | NC_000008.11:g.38424546A>G | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
rs121909633 | p.Ile300Thr | missense variant | Trigonocephaly 1 (TRIGNO1) | NC_000008.11:g.38424546A>G | UniProt,dbSNP |
VAR_030986 | p.Ile300Thr | missense variant | Trigonocephaly 1 (TRIGNO1) | NC_000008.11:g.38424546A>G | UniProt |
RCV000502492 | p.Ile300Thr | missense variant | - | NC_000008.11:g.38424546A>G | ClinVar |
RCV000766015 | p.Ile300Thr | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38424546A>G | ClinVar |
RCV000514891 | p.Ile300Thr | missense variant | - | NC_000008.11:g.38424546A>G | ClinVar |
rs762320540 | p.Gly301Asp | missense variant | - | NC_000008.11:g.38424543C>T | ExAC,gnomAD |
rs896498971 | p.Asn304Ser | missense variant | - | NC_000008.11:g.38424534T>C | TOPMed |
COSM3648891 | p.Gln309Ter | stop gained | Variant assessed as Somatic; HIGH impact. | NC_000008.11:g.38424520G>A | NCI-TCGA Cosmic |
COSM3779210 | p.Leu311Phe | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38424512C>G | NCI-TCGA Cosmic |
rs1342243519 | p.Thr313Ser | missense variant | - | NC_000008.11:g.38421940G>C | TOPMed |
rs755595684 | p.Ala314Val | missense variant | - | NC_000008.11:g.38421937G>A | ExAC,gnomAD |
rs1434741581 | p.Val316Ala | missense variant | - | NC_000008.11:g.38421931A>G | gnomAD |
COSM1099642 | p.Asp320Asn | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38421920C>T | NCI-TCGA Cosmic |
VAR_080328 | p.Glu324_Arg822del | inframe_deletion | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
COSM3900029 | p.Val325Met | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38421905C>T | NCI-TCGA Cosmic |
rs759233744 | p.His327Tyr | missense variant | - | NC_000008.11:g.38421899G>A | ExAC,gnomAD |
rs121909632 | p.Asn330Ile | missense variant | Osteoglophonic dysplasia (ogd) | NC_000008.11:g.38421889T>A | gnomAD |
rs121909632 | p.Asn330Ile | missense variant | Osteoglophonic dysplasia (OGD) | NC_000008.11:g.38421889T>A | UniProt,dbSNP |
VAR_030987 | p.Asn330Ile | missense variant | Osteoglophonic dysplasia (OGD) | NC_000008.11:g.38421889T>A | UniProt |
RCV000017678 | p.Asn330Ile | missense variant | Osteoglophonic dysplasia (OGD) | NC_000008.11:g.38421889T>A | ClinVar |
rs121909632 | p.Asn330Ser | missense variant | Osteoglophonic dysplasia (ogd) | NC_000008.11:g.38421889T>C | gnomAD |
COSM3779206 | p.Ser332Phe | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38421883G>A | NCI-TCGA Cosmic |
VAR_030988 | p.Ser332Cys | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
rs981703846 | p.Ala336Ser | missense variant | - | NC_000008.11:g.38421872C>A | TOPMed,gnomAD |
rs981703846 | p.Ala336Thr | missense variant | - | NC_000008.11:g.38421872C>T | TOPMed,gnomAD |
rs1064793122 | p.Gly337Glu | missense variant | - | NC_000008.11:g.38421868C>T | - |
RCV000478577 | p.Gly337Glu | missense variant | - | NC_000008.11:g.38421868C>T | ClinVar |
VAR_030989 | p.Tyr339Cys | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
RCV000480479 | p.Thr340Met | missense variant | - | NC_000008.11:g.38421859G>A | ClinVar |
rs1064793123 | p.Thr340Met | missense variant | - | NC_000008.11:g.38421859G>A | - |
RCV000030933 | p.Leu342Ser | missense variant | Hypogonadotropic hypogonadism 2 with anosmia | NC_000008.11:g.38421853A>G | ClinVar |
rs121909638 | p.Leu342Ser | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38421853A>G | UniProt,dbSNP |
VAR_069954 | p.Leu342Ser | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38421853A>G | UniProt |
rs121909638 | p.Leu342Ser | missense variant | - | NC_000008.11:g.38421853A>G | - |
VAR_030990 | p.Ala343Val | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
RCV000156958 | p.Ser346Ter | frameshift | Delayed puberty | NC_000008.11:g.38421840_38421841AG[1] | ClinVar |
RCV000156957 | p.Ser346Ter | frameshift | Hypogonadotropic hypogonadism 7 with or without anosmia (HH7) | NC_000008.11:g.38421840_38421841AG[1] | ClinVar |
VAR_030991 | p.Ser346Cys | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
RCV000319353 | p.Gly348Arg | missense variant | - | NC_000008.11:g.38421836C>T | ClinVar |
rs886037634 | p.Gly348Arg | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38421836C>T | UniProt,dbSNP |
VAR_069955 | p.Gly348Arg | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38421836C>T | UniProt |
rs764101526 | p.Ser350Thr | missense variant | - | NC_000008.11:g.38421830A>T | ExAC,gnomAD |
rs1310331035 | p.His351Tyr | missense variant | - | NC_000008.11:g.38421827G>A | gnomAD |
COSM3900025 | p.His352Arg | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38421823T>C | NCI-TCGA Cosmic |
NCI-TCGA novel | p.His352Tyr | missense variant | - | NC_000008.11:g.38421824G>A | NCI-TCGA |
VAR_082843 | p.Ala353Thr | Missense | - | - | UniProt |
RCV000702519 | p.Trp355Ser | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38421814C>G | ClinVar |
rs774768179 | p.Val358Ile | missense variant | - | NC_000008.11:g.38421806C>T | ExAC,gnomAD |
rs1380308168 | p.Leu359Val | missense variant | - | NC_000008.11:g.38421803G>C | gnomAD |
RCV000484860 | p.Glu360Lys | missense variant | - | NC_000008.11:g.38421800C>T | ClinVar |
rs982371464 | p.Glu360Lys | missense variant | - | NC_000008.11:g.38421800C>T | TOPMed,gnomAD |
rs771811718 | p.Ala361Asp | missense variant | - | NC_000008.11:g.38419735G>T | ExAC,TOPMed,gnomAD |
rs768918396 | p.Leu362Pro | missense variant | - | NC_000008.11:g.38419732A>G | ExAC,TOPMed,gnomAD |
rs753838219 | p.Pro366Ser | missense variant | - | NC_000008.11:g.38419721G>A | ExAC,gnomAD |
rs121909641 | p.Pro366Leu | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38419720G>A | UniProt,dbSNP |
VAR_030992 | p.Pro366Leu | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38419720G>A | UniProt |
RCV000156970 | p.Pro366Leu | missense variant | Hypogonadotropic hypogonadism 7 with or without anosmia (HH7) | NC_000008.11:g.38419720G>A | ClinVar |
RCV000763182 | p.Pro366Leu | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38419720G>A | ClinVar |
rs1324436328 | p.Ala367Val | missense variant | - | NC_000008.11:g.38419717G>A | TOPMed,gnomAD |
rs756016701 | p.Ala367Ser | missense variant | - | NC_000008.11:g.38419718C>A | ExAC,gnomAD |
rs1317322082 | p.Val368Met | missense variant | - | NC_000008.11:g.38419715C>T | gnomAD |
rs1404194266 | p.Met369Ile | missense variant | - | NC_000008.11:g.38419710C>A | gnomAD |
rs1404194266 | p.Met369Ile | missense variant | - | NC_000008.11:g.38419710C>T | gnomAD |
rs751688900 | p.Met369Lys | missense variant | - | NC_000008.11:g.38419711A>T | ExAC,TOPMed,gnomAD |
rs751688900 | p.Met369Thr | missense variant | - | NC_000008.11:g.38419711A>G | ExAC,TOPMed,gnomAD |
rs961818413 | p.Ser371Leu | missense variant | - | NC_000008.11:g.38419705G>A | TOPMed |
rs377648976 | p.Pro372Ser | missense variant | - | NC_000008.11:g.38419703G>A | ESP,ExAC,TOPMed,gnomAD |
rs121909631 | p.Tyr374Cys | missense variant | Osteoglophonic dysplasia (ogd) | NC_000008.11:g.38419696T>C | - |
rs121909631 | p.Tyr374Cys | missense variant | Osteoglophonic dysplasia (OGD) | NC_000008.11:g.38419696T>C | UniProt,dbSNP |
VAR_030993 | p.Tyr374Cys | missense variant | Osteoglophonic dysplasia (OGD) | NC_000008.11:g.38419696T>C | UniProt |
RCV000017679 | p.Tyr374Cys | missense variant | Osteoglophonic dysplasia (OGD) | NC_000008.11:g.38419696T>C | ClinVar |
rs984502740 | p.Leu375Val | missense variant | - | NC_000008.11:g.38419694G>C | gnomAD |
rs374135854 | p.Ile379Thr | missense variant | - | NC_000008.11:g.38419681A>G | ESP,ExAC,TOPMed,gnomAD |
rs777103792 | p.Tyr380Cys | missense variant | - | NC_000008.11:g.38419678T>C | ExAC,gnomAD |
RCV000729386 | p.Tyr380His | missense variant | - | NC_000008.11:g.38419679A>G | ClinVar |
rs121909634 | p.Cys381Arg | missense variant | Osteoglophonic dysplasia (ogd) | NC_000008.11:g.38419676A>G | - |
rs121909634 | p.Cys381Arg | missense variant | Osteoglophonic dysplasia (OGD) | NC_000008.11:g.38419676A>G | UniProt,dbSNP |
VAR_030994 | p.Cys381Arg | missense variant | Osteoglophonic dysplasia (OGD) | NC_000008.11:g.38419676A>G | UniProt |
RCV000017682 | p.Cys381Arg | missense variant | Osteoglophonic dysplasia (OGD) | NC_000008.11:g.38419676A>G | ClinVar |
rs1028642828 | p.Thr382Ile | missense variant | - | NC_000008.11:g.38419672G>A | - |
rs1288519915 | p.Gly383Ala | missense variant | - | NC_000008.11:g.38419669C>G | gnomAD |
rs1210327784 | p.Ala384Ser | missense variant | - | NC_000008.11:g.38419667C>A | TOPMed,gnomAD |
rs1210327784 | p.Ala384Pro | missense variant | - | NC_000008.11:g.38419667C>G | TOPMed,gnomAD |
rs761247988 | p.Leu386Phe | missense variant | - | NC_000008.11:g.38419661G>A | ExAC,gnomAD |
rs768687116 | p.Ile387Val | missense variant | - | NC_000008.11:g.38419658T>C | ExAC,gnomAD |
rs370205081 | p.Ser388Phe | missense variant | - | NC_000008.11:g.38419654G>A | ESP,ExAC,TOPMed,gnomAD |
rs376921992 | p.Met390Val | missense variant | - | NC_000008.11:g.38419649T>C | ESP,ExAC,gnomAD |
rs527372786 | p.Val391Ala | missense variant | - | NC_000008.11:g.38419645A>G | 1000Genomes,ExAC,TOPMed,gnomAD |
rs202073071 | p.Val391Met | missense variant | - | NC_000008.11:g.38419646C>T | TOPMed,gnomAD |
rs202073071 | p.Val391Leu | missense variant | - | NC_000008.11:g.38419646C>A | TOPMed,gnomAD |
rs369059499 | p.Ser393Leu | missense variant | - | NC_000008.11:g.38419639G>A | ESP,ExAC,TOPMed,gnomAD |
rs752627281 | p.Val396Ile | missense variant | - | NC_000008.11:g.38419631C>T | ExAC,TOPMed,gnomAD |
rs1395234901 | p.Tyr397His | missense variant | - | NC_000008.11:g.38419628A>G | gnomAD |
rs1164263883 | p.Lys398Glu | missense variant | - | NC_000008.11:g.38419625T>C | gnomAD |
rs1473969370 | p.Lys398Arg | missense variant | - | NC_000008.11:g.38419624T>C | gnomAD |
rs1416395686 | p.Met399Val | missense variant | - | NC_000008.11:g.38419622T>C | TOPMed,gnomAD |
rs1187822240 | p.Ser401Thr | missense variant | - | NC_000008.11:g.38419615C>G | gnomAD |
rs758359914 | p.His409Gln | missense variant | - | NC_000008.11:g.38419590G>C | ExAC,gnomAD |
rs1441745837 | p.Ser410Gly | missense variant | - | NC_000008.11:g.38419589T>C | TOPMed |
rs750688817 | p.Ser410Asn | missense variant | - | NC_000008.11:g.38419588C>T | ExAC,TOPMed,gnomAD |
rs765415311 | p.Met412Val | missense variant | - | NC_000008.11:g.38419583T>C | ExAC,gnomAD |
rs1210272196 | p.Val414Met | missense variant | - | NC_000008.11:g.38419577C>T | gnomAD |
rs1271245426 | p.Ala418Val | missense variant | - | NC_000008.11:g.38419564G>A | gnomAD |
rs1232639613 | p.Lys419Arg | missense variant | - | NC_000008.11:g.38419561T>C | gnomAD |
COSM3648875 | p.Lys419Glu | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38419562T>C | NCI-TCGA Cosmic |
rs1289681665 | p.Ser420Asn | missense variant | - | NC_000008.11:g.38419558C>T | TOPMed,gnomAD |
NCI-TCGA novel | p.Ile421Thr | missense variant | - | NC_000008.11:g.38419555A>G | NCI-TCGA |
rs183376882 | p.Arg424His | missense variant | - | NC_000008.11:g.38419546C>T | 1000Genomes,ExAC,TOPMed,gnomAD |
rs369096310 | p.Arg424Cys | missense variant | - | NC_000008.11:g.38419547G>A | ESP,ExAC,TOPMed,gnomAD |
rs767080647 | p.Arg425Ile | missense variant | - | NC_000008.11:g.38419543C>A | ExAC,gnomAD |
NCI-TCGA novel | p.Ser430Phe | missense variant | - | NC_000008.11:g.38418369G>A | NCI-TCGA |
rs1302224608 | p.Ala431Thr | missense variant | - | NC_000008.11:g.38418367C>T | gnomAD |
rs375914079 | p.Ser434Gly | missense variant | - | NC_000008.11:g.38418358T>C | ESP,TOPMed |
rs772794963 | p.Ser434Arg | missense variant | - | NC_000008.11:g.38418356A>C | ExAC,gnomAD |
rs769607850 | p.Ala435Val | missense variant | - | NC_000008.11:g.38418354G>A | ExAC,gnomAD |
COSM4162977 | p.Ser436Phe | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38418351G>A | NCI-TCGA Cosmic |
rs747976513 | p.Ser436Cys | missense variant | - | NC_000008.11:g.38418351G>C | ExAC,gnomAD |
rs768532728 | p.Ser439Cys | missense variant | - | NC_000008.11:g.38418342G>C | ExAC,gnomAD |
rs372654433 | p.Gly440Glu | missense variant | - | NC_000008.11:g.38418339C>T | ESP,ExAC,TOPMed,gnomAD |
rs778861510 | p.Val441Phe | missense variant | - | NC_000008.11:g.38418337C>A | ExAC,gnomAD |
RCV000030935 | p.Val441Ter | frameshift | Hypogonadotropic hypogonadism 2 with anosmia | NC_000008.11:g.38418340_38418341del | ClinVar |
rs778861510 | p.Val441Ile | missense variant | - | NC_000008.11:g.38418337C>T | ExAC,gnomAD |
rs778104598 | p.Leu442Val | missense variant | - | NC_000008.11:g.38418334G>C | ExAC,TOPMed,gnomAD |
rs778104598 | p.Leu442Phe | missense variant | - | NC_000008.11:g.38418334G>A | ExAC,TOPMed,gnomAD |
rs756375285 | p.Leu443Pro | missense variant | - | NC_000008.11:g.38418330A>G | ExAC,TOPMed,gnomAD |
rs367715495 | p.Arg445Gln | missense variant | - | NC_000008.11:g.38418324C>T | ESP,ExAC,TOPMed,gnomAD |
rs781608303 | p.Arg445Trp | missense variant | - | NC_000008.11:g.38418325G>A | ExAC,gnomAD |
rs752038121 | p.Pro446Ser | missense variant | - | NC_000008.11:g.38418322G>A | ExAC,gnomAD |
rs765888792 | p.Pro446Leu | missense variant | - | NC_000008.11:g.38418321G>A | ExAC,TOPMed,gnomAD |
rs749903780 | p.Arg448Trp | missense variant | - | NC_000008.11:g.38418316G>A | ExAC,gnomAD |
rs758138124 | p.Arg448Leu | missense variant | - | NC_000008.11:g.38418315C>A | ExAC,TOPMed,gnomAD |
RCV000540340 | p.Arg448Gln | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38418315C>T | ClinVar |
rs758138124 | p.Arg448Gln | missense variant | - | NC_000008.11:g.38418315C>T | ExAC,TOPMed,gnomAD |
RCV000757294 | p.Arg448Gln | missense variant | - | NC_000008.11:g.38418315C>T | ClinVar |
rs374672119 | p.Ser451Cys | missense variant | - | NC_000008.11:g.38418306G>C | ESP,TOPMed,gnomAD |
NCI-TCGA novel | p.Ser451Phe | missense variant | - | NC_000008.11:g.38418306G>A | NCI-TCGA |
rs948384958 | p.Ser452Arg | missense variant | - | NC_000008.11:g.38418304T>G | gnomAD |
rs948384958 | p.Ser452Cys | missense variant | - | NC_000008.11:g.38418304T>A | gnomAD |
rs575766741 | p.Pro455Ala | missense variant | - | NC_000008.11:g.38418295G>C | 1000Genomes,ExAC,TOPMed,gnomAD |
rs575766741 | p.Pro455Ser | missense variant | - | NC_000008.11:g.38418295G>A | 1000Genomes,ExAC,TOPMed,gnomAD |
rs200776757 | p.Met456Ile | missense variant | - | NC_000008.11:g.38418290C>A | ESP,ExAC,TOPMed,gnomAD |
RCV000408775 | p.Met456Ile | missense variant | Craniosynostosis, nonspecific | NC_000008.11:g.38418290C>A | ClinVar |
rs768428215 | p.Met456Val | missense variant | - | NC_000008.11:g.38418292T>C | ExAC,gnomAD |
rs985869735 | p.Ala458Thr | missense variant | - | NC_000008.11:g.38418286C>T | TOPMed |
rs1463733617 | p.Gly459Ala | missense variant | - | NC_000008.11:g.38418282C>G | gnomAD |
NCI-TCGA novel | p.Gly459Arg | missense variant | - | NC_000008.11:g.38418283C>T | NCI-TCGA |
rs775445657 | p.Val460Ile | missense variant | - | NC_000008.11:g.38418280C>T | ExAC,TOPMed,gnomAD |
rs775445657 | p.Val460Phe | missense variant | - | NC_000008.11:g.38418280C>A | ExAC,TOPMed,gnomAD |
COSM3648865 | p.Ser461Phe | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38418276G>A | NCI-TCGA Cosmic |
rs367955950 | p.Glu462Gly | missense variant | - | NC_000008.11:g.38418273T>C | ESP,ExAC,TOPMed,gnomAD |
rs746082633 | p.Tyr463Cys | missense variant | - | NC_000008.11:g.38418270T>C | ExAC,TOPMed,gnomAD |
rs1189940197 | p.Leu465Ile | missense variant | - | NC_000008.11:g.38418265G>T | gnomAD |
NCI-TCGA novel | p.Pro466Leu | missense variant | - | NC_000008.11:g.38418261G>A | NCI-TCGA |
rs923019674 | p.Glu467Lys | missense variant | - | NC_000008.11:g.38418259C>T | TOPMed,gnomAD |
rs781310679 | p.Arg470Cys | missense variant | - | NC_000008.11:g.38418250G>A | ExAC,TOPMed,gnomAD |
rs121909637 | p.Arg470His | missense variant | - | NC_000008.11:g.38418249C>T | 1000Genomes,ExAC,TOPMed,gnomAD |
COSM1137868 | p.Arg470Pro | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38418249C>G | NCI-TCGA Cosmic |
RCV000030932 | p.Arg470Leu | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38418249C>A | ClinVar |
rs121909637 | p.Arg470Leu | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38418249C>A | UniProt,dbSNP |
VAR_069292 | p.Arg470Leu | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38418249C>A | UniProt |
rs121909637 | p.Arg470Leu | missense variant | - | NC_000008.11:g.38418249C>A | 1000Genomes,ExAC,TOPMed,gnomAD |
rs780577173 | p.Leu473Val | missense variant | - | NC_000008.11:g.38418241G>C | ExAC |
rs575227358 | p.Pro474Ala | missense variant | - | NC_000008.11:g.38418238G>C | 1000Genomes,ExAC,gnomAD |
RCV000514316 | p.Arg475Gln | missense variant | - | NC_000008.11:g.38418234C>T | ClinVar |
COSM3900015 | p.Arg475Trp | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38418235G>A | NCI-TCGA Cosmic |
rs747333248 | p.Arg475Gln | missense variant | - | NC_000008.11:g.38418234C>T | ExAC,TOPMed,gnomAD |
rs1275391593 | p.Arg477Lys | missense variant | - | NC_000008.11:g.38418228C>T | gnomAD |
rs778403497 | p.Gly481Ser | missense variant | - | NC_000008.11:g.38417981C>T | ExAC,gnomAD |
rs397515444 | p.Pro483Thr | missense variant | - | NC_000008.11:g.38417975G>T | ExAC,gnomAD |
rs397515444 | p.Pro483Thr | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38417975G>T | UniProt,dbSNP |
VAR_069956 | p.Pro483Thr | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38417975G>T | UniProt |
rs753460572 | p.Pro483Arg | missense variant | - | NC_000008.11:g.38417974G>C | ExAC,gnomAD |
COSM3648850 | p.Pro483Leu | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38417974G>A | NCI-TCGA Cosmic |
RCV000043589 | p.Pro483Thr | missense variant | Hypogonadotropic hypogonadism 2 with anosmia | NC_000008.11:g.38417975G>T | ClinVar |
rs397515444 | p.Pro483Ser | missense variant | - | NC_000008.11:g.38417975G>A | ExAC,gnomAD |
rs876661332 | p.Gly485Val | missense variant | - | NC_000008.11:g.38417968C>A | - |
COSM1314030 | p.Gly485Ala | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38417968C>G | NCI-TCGA Cosmic |
RCV000223739 | p.Gly485Val | missense variant | Hartsfield syndrome | NC_000008.11:g.38417968C>A | ClinVar |
RCV000591024 | p.Gly487Asp | missense variant | Hartsfield syndrome | NC_000008.11:g.38417962C>T | ClinVar |
RCV000119059 | p.Gly487Asp | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38417962C>T | ClinVar |
rs515726224 | p.Gly487Asp | missense variant | - | NC_000008.11:g.38417962C>T | - |
rs869025670 | p.Gly490Arg | missense variant | - | NC_000008.11:g.38417954C>T | - |
RCV000208875 | p.Gly490Arg | missense variant | Hartsfield syndrome | NC_000008.11:g.38417954C>G | ClinVar |
RCV000417937 | p.Gly490Arg | missense variant | - | NC_000008.11:g.38417954C>T | ClinVar |
rs869025670 | p.Gly490Arg | missense variant | - | NC_000008.11:g.38417954C>G | - |
rs752601407 | p.Val493Met | missense variant | - | NC_000008.11:g.38417945C>T | ExAC,gnomAD |
rs1192215028 | p.Ala497Val | missense variant | - | NC_000008.11:g.38417932G>A | gnomAD |
rs938924493 | p.Ala497Pro | missense variant | - | NC_000008.11:g.38417933C>G | gnomAD |
rs938924493 | p.Ala497Thr | missense variant | - | NC_000008.11:g.38417933C>T | gnomAD |
rs767419329 | p.Ile498Val | missense variant | - | NC_000008.11:g.38417930T>C | ExAC,TOPMed,gnomAD |
rs759552236 | p.Gly499Arg | missense variant | - | NC_000008.11:g.38417927C>T | ExAC,gnomAD |
rs1485152215 | p.Gly499Glu | missense variant | - | NC_000008.11:g.38417926C>T | gnomAD |
rs1260234772 | p.Leu500Val | missense variant | - | NC_000008.11:g.38417924G>C | gnomAD |
rs1233979323 | p.Asp501Gly | missense variant | - | NC_000008.11:g.38417920T>C | gnomAD |
rs372521005 | p.Asp503Glu | missense variant | - | NC_000008.11:g.38417913G>C | ESP,ExAC,TOPMed,gnomAD |
rs572845338 | p.Asn506Ser | missense variant | - | NC_000008.11:g.38417905T>C | 1000Genomes,ExAC,TOPMed,gnomAD |
rs572845338 | p.Asn506Thr | missense variant | - | NC_000008.11:g.38417905T>G | 1000Genomes,ExAC,TOPMed,gnomAD |
RCV000498726 | p.Arg507His | missense variant | - | NC_000008.11:g.38417902C>T | ClinVar |
rs369356672 | p.Arg507His | missense variant | - | NC_000008.11:g.38417902C>T | ESP,ExAC,TOPMed,gnomAD |
rs776549085 | p.Arg507Ser | missense variant | - | NC_000008.11:g.38417903G>T | ExAC,gnomAD |
rs776549085 | p.Arg507Cys | missense variant | - | NC_000008.11:g.38417903G>A | ExAC,gnomAD |
rs1440198956 | p.Ala512Gly | missense variant | - | NC_000008.11:g.38417887G>C | TOPMed |
rs77988343 | p.Val513Gly | missense variant | - | NC_000008.11:g.38417884A>C | ExAC,gnomAD |
rs1085307722 | p.Val513Met | missense variant | - | NC_000008.11:g.38417885C>T | - |
rs77988343 | p.Val513Ala | missense variant | - | NC_000008.11:g.38417884A>G | ExAC,gnomAD |
RCV000489322 | p.Val513Met | missense variant | - | NC_000008.11:g.38417885C>T | ClinVar |
RCV000419230 | p.Met515Val | missense variant | Adenocarcinoma of stomach | NC_000008.11:g.38417879T>C | ClinVar |
RCV000436467 | p.Met515Val | missense variant | Neuroblastoma (NBLST1) | NC_000008.11:g.38417879T>C | ClinVar |
RCV000418590 | p.Met515Val | missense variant | Medulloblastoma (MDB) | NC_000008.11:g.38417879T>C | ClinVar |
RCV000435727 | p.Met515Val | missense variant | Astrocytoma | NC_000008.11:g.38417879T>C | ClinVar |
RCV000429290 | p.Met515Val | missense variant | - | NC_000008.11:g.38417879T>C | ClinVar |
rs746392282 | p.Met515Thr | missense variant | - | NC_000008.11:g.38417878A>G | ExAC,gnomAD |
rs1057519899 | p.Met515Val | missense variant | - | NC_000008.11:g.38417879T>C | - |
rs774678297 | p.Ser518Leu | missense variant | - | NC_000008.11:g.38417416G>A | ExAC,TOPMed,gnomAD |
rs749758370 | p.Ala520Thr | missense variant | - | NC_000008.11:g.38417411C>T | ExAC,TOPMed,gnomAD |
rs749758370 | p.Ala520Thr | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38417411C>T | UniProt,dbSNP |
VAR_030995 | p.Ala520Thr | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38417411C>T | UniProt |
rs1255503690 | p.Asp524Ala | missense variant | - | NC_000008.11:g.38417398T>G | gnomAD |
rs1554551706 | p.Ser530Ter | stop gained | - | NC_000008.11:g.38417380G>T | - |
RCV000627342 | p.Ser530Ter | nonsense | - | NC_000008.11:g.38417380G>T | ClinVar |
RCV000481922 | p.Met532Thr | missense variant | - | NC_000008.11:g.38417374A>G | ClinVar |
rs777345476 | p.Met532Thr | missense variant | - | NC_000008.11:g.38417374A>G | ExAC,TOPMed,gnomAD |
rs530348127 | p.Met534Val | missense variant | - | NC_000008.11:g.38417369T>C | 1000Genomes,TOPMed,gnomAD |
RCV000591009 | p.Met535Lys | missense variant | Hartsfield syndrome | NC_000008.11:g.38417365A>T | ClinVar |
rs1554551667 | p.Met535Lys | missense variant | - | NC_000008.11:g.38417365A>T | - |
rs769129551 | p.Met537Val | missense variant | - | NC_000008.11:g.38417360T>C | ExAC,gnomAD |
rs747825610 | p.Ile538Met | missense variant | - | NC_000008.11:g.38417355G>C | ExAC,TOPMed,gnomAD |
COSM1456917 | p.Ile538Thr | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38417356A>G | NCI-TCGA Cosmic |
VAR_030996 | p.Ile538Val | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
rs780953869 | p.Gly539Glu | missense variant | - | NC_000008.11:g.38417353C>T | ExAC,gnomAD |
rs201158796 | p.Gly539Arg | missense variant | - | NC_000008.11:g.38417354C>T | gnomAD |
RCV000369604 | p.Gly539Arg | missense variant | Hypogonadism with anosmia (KS) | NC_000008.11:g.38417354C>T | ClinVar |
RCV000298552 | p.Gly539Arg | missense variant | - | NC_000008.11:g.38417354C>T | ClinVar |
RCV000329967 | p.Gly539Arg | missense variant | Pfeiffer syndrome (ACS5) | NC_000008.11:g.38417354C>T | ClinVar |
RCV000259751 | p.Gly539Arg | missense variant | Osteoglophonic dysplasia (OGD) | NC_000008.11:g.38417354C>T | ClinVar |
RCV000277344 | p.Gly539Arg | missense variant | Nonsyndromic Trigonocephaly | NC_000008.11:g.38417354C>T | ClinVar |
NCI-TCGA novel | p.Lys540Thr | missense variant | - | NC_000008.11:g.38417350T>G | NCI-TCGA |
rs559692139 | p.His541Tyr | missense variant | - | NC_000008.11:g.38417348G>A | 1000Genomes,ExAC,gnomAD |
rs1336044788 | p.Ile545Leu | missense variant | - | NC_000008.11:g.38417336T>G | gnomAD |
RCV000487433 | p.Asn546Lys | missense variant | - | NC_000008.11:g.38417331G>T | ClinVar |
RCV000443832 | p.Asn546Asp | missense variant | Adenocarcinoma of stomach | NC_000008.11:g.38417333T>C | ClinVar |
RCV000424432 | p.Asn546Asp | missense variant | Astrocytoma | NC_000008.11:g.38417333T>C | ClinVar |
RCV000435153 | p.Asn546Asp | missense variant | - | NC_000008.11:g.38417333T>C | ClinVar |
RCV000443693 | p.Asn546Asp | missense variant | Medulloblastoma (MDB) | NC_000008.11:g.38417333T>C | ClinVar |
RCV000425019 | p.Asn546Asp | missense variant | Neuroblastoma (NBLST1) | NC_000008.11:g.38417333T>C | ClinVar |
rs1057519898 | p.Asn546Asp | missense variant | - | NC_000008.11:g.38417333T>C | - |
rs779707422 | p.Asn546Lys | missense variant | - | NC_000008.11:g.38417331G>T | ExAC,TOPMed,gnomAD |
rs758360392 | p.Leu547Val | missense variant | - | NC_000008.11:g.38417330G>C | ExAC,gnomAD |
rs764252845 | p.Cys551Ser | missense variant | - | NC_000008.11:g.38417317C>G | ExAC,TOPMed,gnomAD |
rs760702592 | p.Thr552Met | missense variant | - | NC_000008.11:g.38417314G>A | ExAC,gnomAD |
NCI-TCGA novel | p.Gln553His | missense variant | - | NC_000008.11:g.38417310C>A | NCI-TCGA |
RCV000437928 | p.Asp554Asn | missense variant | - | NC_000008.11:g.38417309C>T | ClinVar |
rs1057524808 | p.Asp554Asn | missense variant | - | NC_000008.11:g.38417309C>T | - |
rs1340570003 | p.Gly555Val | missense variant | - | NC_000008.11:g.38416060C>A | TOPMed |
rs1243758431 | p.Pro556Leu | missense variant | - | NC_000008.11:g.38416057G>A | gnomAD |
RCV000722312 | p.Leu557Phe | missense variant | - | NC_000008.11:g.38416053C>A | ClinVar |
rs762402991 | p.Ile560Thr | missense variant | - | NC_000008.11:g.38416045A>G | ExAC,gnomAD |
VAR_075854 | p.Val561Met | Missense | - | - | UniProt |
rs768223019 | p.Ser565Phe | missense variant | - | NC_000008.11:g.38416030G>A | ExAC,gnomAD |
rs768223019 | p.Ser565Cys | missense variant | - | NC_000008.11:g.38416030G>C | ExAC,gnomAD |
rs531903077 | p.Lys566Arg | missense variant | - | NC_000008.11:g.38416027T>C | 1000Genomes,gnomAD |
rs1399523084 | p.Arg570Gln | missense variant | - | NC_000008.11:g.38416015C>T | gnomAD |
RCV000449624 | p.Glu571Ter | frameshift | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38416015del | ClinVar |
rs771720144 | p.Glu571Lys | missense variant | - | NC_000008.11:g.38416013C>T | ExAC,gnomAD |
NCI-TCGA novel | p.Gln574His | missense variant | - | NC_000008.11:g.38416002C>A | NCI-TCGA |
rs903239767 | p.Gln574Arg | missense variant | - | NC_000008.11:g.38416003T>C | TOPMed |
rs1482868825 | p.Arg576Gln | missense variant | - | NC_000008.11:g.38415997C>T | TOPMed |
rs1175162486 | p.Pro579Leu | missense variant | - | NC_000008.11:g.38415988G>A | gnomAD |
rs1410298719 | p.Gly580Trp | missense variant | - | NC_000008.11:g.38415986C>A | gnomAD |
rs745696130 | p.Cys584Trp | missense variant | - | NC_000008.11:g.38415972G>C | ExAC,gnomAD |
rs1477426230 | p.Tyr585His | missense variant | - | NC_000008.11:g.38415971A>G | gnomAD |
rs757254917 | p.Asn586Ile | missense variant | - | NC_000008.11:g.38415967T>A | ExAC,gnomAD |
rs757254917 | p.Asn586Thr | missense variant | - | NC_000008.11:g.38415967T>G | ExAC,gnomAD |
RCV000414346 | p.Ser588Ter | frameshift | - | NC_000008.11:g.38415955_38415965del | ClinVar |
rs1484524877 | p.His589Gln | missense variant | - | NC_000008.11:g.38415957G>T | gnomAD |
rs1271149897 | p.Asn590Asp | missense variant | - | NC_000008.11:g.38415956T>C | TOPMed |
rs781268209 | p.Pro591Leu | missense variant | - | NC_000008.11:g.38415952G>A | ExAC,gnomAD |
rs755002934 | p.Glu592Lys | missense variant | - | NC_000008.11:g.38415950C>T | ExAC,gnomAD |
rs751840290 | p.Glu592Ala | missense variant | - | NC_000008.11:g.38415949T>G | ExAC,TOPMed,gnomAD |
rs751840290 | p.Glu592Gly | missense variant | - | NC_000008.11:g.38415949T>C | ExAC,TOPMed,gnomAD |
rs1271277323 | p.Glu593Lys | missense variant | - | NC_000008.11:g.38415947C>T | gnomAD |
rs1373408534 | p.Gln594Arg | missense variant | - | NC_000008.11:g.38415943T>C | TOPMed |
rs1463369542 | p.Ser596Tyr | missense variant | - | NC_000008.11:g.38415937G>T | TOPMed |
rs1336034253 | p.Lys598Thr | missense variant | - | NC_000008.11:g.38415931T>G | TOPMed,gnomAD |
COSM3648840 | p.Ser602Phe | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38415919G>A | NCI-TCGA Cosmic |
rs1424914793 | p.Cys603Ser | missense variant | - | NC_000008.11:g.38415916C>G | TOPMed |
rs1412996644 | p.Ala604Thr | missense variant | - | NC_000008.11:g.38415914C>T | gnomAD |
RCV000030927 | p.Val607Met | missense variant | Hypogonadotropic hypogonadism 2 with anosmia | NC_000008.11:g.38415905C>T | ClinVar |
rs121909629 | p.Val607Met | missense variant | - | NC_000008.11:g.38415905C>T | - |
rs121909629 | p.Val607Met | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38415905C>T | UniProt,dbSNP |
VAR_017889 | p.Val607Met | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38415905C>T | UniProt |
rs765629435 | p.Arg609Gln | missense variant | - | NC_000008.11:g.38415898C>T | ExAC,gnomAD |
RCV000478244 | p.Arg609Ter | nonsense | - | NC_000008.11:g.38415899G>A | ClinVar |
RCV000500417 | p.Arg609Ter | nonsense | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38415899G>A | ClinVar |
COSM260938 | p.Gly610Asp | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38415895C>T | NCI-TCGA Cosmic |
rs1343172545 | p.Glu612Gln | missense variant | - | NC_000008.11:g.38415890C>G | TOPMed |
RCV000484557 | p.Tyr613Cys | missense variant | - | NC_000008.11:g.38415886T>C | ClinVar |
rs1064793124 | p.Tyr613Cys | missense variant | - | NC_000008.11:g.38415886T>C | - |
rs1554549628 | p.Tyr613Ter | stop gained | - | NC_000008.11:g.38415885A>C | - |
RCV000521212 | p.Tyr613Ter | nonsense | - | NC_000008.11:g.38415885A>C | ClinVar |
rs777228638 | p.Ala615Ser | missense variant | - | NC_000008.11:g.38415881C>A | ExAC,gnomAD |
NCI-TCGA novel | p.Lys618Asn | missense variant | - | NC_000008.11:g.38415870C>A | NCI-TCGA |
VAR_069293 | p.Lys618Asn | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
VAR_030997 | p.His621Arg | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
RCV000255867 | p.Arg622Gly | missense variant | - | NC_000008.11:g.38414892G>C | ClinVar |
RCV000156953 | p.Arg622Ter | nonsense | Hypogonadotropic hypogonadism 7 with or without anosmia (HH7) | NC_000008.11:g.38414892G>A | ClinVar |
RCV000156954 | p.Arg622Ter | nonsense | Delayed puberty | NC_000008.11:g.38414892G>A | ClinVar |
rs121909628 | p.Arg622Gly | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38414892G>C | UniProt,dbSNP |
VAR_030998 | p.Arg622Gly | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38414892G>C | UniProt |
VAR_080329 | p.Arg622_Arg822del | inframe_deletion | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
VAR_030999 | p.Arg622Gln | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
rs780009859 | p.Asp623Glu | missense variant | - | NC_000008.11:g.38414887G>C | ExAC,TOPMed,gnomAD |
RCV000625696 | p.Asp623Glu | missense variant | Hartsfield syndrome | NC_000008.11:g.38414887G>C | ClinVar |
RCV000056315 | p.Asp623Tyr | missense variant | Hartsfield syndrome | NC_000008.11:g.38414889C>A | ClinVar |
rs398122946 | p.Asp623Tyr | missense variant | Hartsfield syndrome (HRTFDS) | NC_000008.11:g.38414889C>A | UniProt,dbSNP |
VAR_070854 | p.Asp623Tyr | missense variant | Hartsfield syndrome (HRTFDS) | NC_000008.11:g.38414889C>A | UniProt |
rs398122946 | p.Asp623Tyr | missense variant | Hartsfield syndrome (hrtfds) | NC_000008.11:g.38414889C>A | - |
RCV000779636 | p.Arg627Ser | missense variant | Hartsfield syndrome | NC_000008.11:g.38414875C>G | ClinVar |
RCV000208873 | p.Arg627Thr | missense variant | Hartsfield syndrome | NC_000008.11:g.38414876C>G | ClinVar |
rs869025671 | p.Arg627Thr | missense variant | - | NC_000008.11:g.38414876C>G | - |
RCV000208876 | p.Asn628Lys | missense variant | Hartsfield syndrome | NC_000008.11:g.38414872A>C | ClinVar |
rs869025672 | p.Asn628Lys | missense variant | - | NC_000008.11:g.38414872A>C | TOPMed,gnomAD |
COSM1137867 | p.Val629Leu | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38414871C>G | NCI-TCGA Cosmic |
rs544967630 | p.Asn635Ile | missense variant | - | NC_000008.11:g.38414852T>A | 1000Genomes,ExAC,TOPMed,gnomAD |
rs544967630 | p.Asn635Ser | missense variant | - | NC_000008.11:g.38414852T>C | 1000Genomes,ExAC,TOPMed,gnomAD |
rs727505370 | p.Ile639Thr | missense variant | - | NC_000008.11:g.38414840A>G | - |
RCV000156955 | p.Ile639Thr | missense variant | Hypogonadotropic hypogonadism 7 with or without anosmia (HH7) | NC_000008.11:g.38414840A>G | ClinVar |
RCV000156956 | p.Ile639Thr | missense variant | Delayed puberty | NC_000008.11:g.38414840A>G | ClinVar |
RCV000614143 | p.Asp641Asn | missense variant | Hartsfield syndrome | NC_000008.11:g.38414835C>T | ClinVar |
rs1554548253 | p.Asp641Asn | missense variant | - | NC_000008.11:g.38414835C>T | - |
rs876661333 | p.Gly643Asp | missense variant | - | NC_000008.11:g.38414828C>T | - |
RCV000223914 | p.Gly643Asp | missense variant | microform holoprosencephaly | NC_000008.11:g.38414828C>T | ClinVar |
rs1484920710 | p.Arg646Gln | missense variant | - | NC_000008.11:g.38414819C>T | gnomAD |
rs1388442293 | p.Asp647Asn | missense variant | - | NC_000008.11:g.38414817C>T | TOPMed |
rs1466727439 | p.Ile648Val | missense variant | - | NC_000008.11:g.38414814T>C | TOPMed |
rs1211901113 | p.His649Asn | missense variant | - | NC_000008.11:g.38414811G>T | gnomAD |
COSM1099630 | p.Ile651Thr | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38414804A>G | NCI-TCGA Cosmic |
rs1350237414 | p.Ile651Val | missense variant | - | NC_000008.11:g.38414805T>C | gnomAD |
rs751038400 | p.Asp652Asn | missense variant | - | NC_000008.11:g.38414802C>T | ExAC,gnomAD |
rs751038400 | p.Asp652Tyr | missense variant | - | NC_000008.11:g.38414802C>A | ExAC,gnomAD |
rs577599441 | p.Tyr653Cys | missense variant | - | NC_000008.11:g.38414798T>C | 1000Genomes,ExAC,gnomAD |
RCV000441552 | p.Lys656Glu | missense variant | Medulloblastoma (MDB) | NC_000008.11:g.38414790T>C | ClinVar |
rs869320694 | p.Lys656Glu | missense variant | - | NC_000008.11:g.38414790T>C | - |
rs869320694 | p.Lys656Glu | missense variant | Encephalocraniocutaneous lipomatosis (ECCL) | NC_000008.11:g.38414790T>C | UniProt,dbSNP |
VAR_075855 | p.Lys656Glu | missense variant | Encephalocraniocutaneous lipomatosis (ECCL) | NC_000008.11:g.38414790T>C | UniProt |
RCV000437662 | p.Lys656Asn | missense variant | Medulloblastoma (MDB) | NC_000008.11:g.38414788C>G | ClinVar |
RCV000430840 | p.Lys656Glu | missense variant | Astrocytoma | NC_000008.11:g.38414790T>C | ClinVar |
RCV000443011 | p.Lys656Asn | missense variant | Astrocytoma | NC_000008.11:g.38414788C>G | ClinVar |
RCV000444182 | p.Lys656Asn | missense variant | Glioblastoma | NC_000008.11:g.38414788C>G | ClinVar |
NCI-TCGA novel | p.Lys656Asn | missense variant | - | NC_000008.11:g.38414788C>A | NCI-TCGA |
RCV000433539 | p.Lys656Asn | missense variant | - | NC_000008.11:g.38414788C>G | ClinVar |
RCV000422833 | p.Lys656Asn | missense variant | Hepatocellular carcinoma (HCC) | NC_000008.11:g.38414788C>G | ClinVar |
RCV000420790 | p.Lys656Glu | missense variant | Lymphoblastic leukemia, acute, with lymphomatous features (LALL) | NC_000008.11:g.38414790T>C | ClinVar |
RCV000438709 | p.Lys656Glu | missense variant | Hepatocellular carcinoma (HCC) | NC_000008.11:g.38414790T>C | ClinVar |
RCV000428027 | p.Lys656Glu | missense variant | - | NC_000008.11:g.38414790T>C | ClinVar |
RCV000420160 | p.Lys656Glu | missense variant | Glioblastoma | NC_000008.11:g.38414790T>C | ClinVar |
RCV000426798 | p.Lys656Asn | missense variant | Lymphoblastic leukemia, acute, with lymphomatous features (LALL) | NC_000008.11:g.38414788C>G | ClinVar |
rs1057519897 | p.Lys656Asn | missense variant | - | NC_000008.11:g.38414788C>G | gnomAD |
rs1337818472 | p.Asn659Ser | missense variant | - | NC_000008.11:g.38414780T>C | TOPMed,gnomAD |
rs1360444997 | p.Asn659Asp | missense variant | - | NC_000008.11:g.38414781T>C | TOPMed,gnomAD |
NCI-TCGA novel | p.Gly660Cys | missense variant | - | NC_000008.11:g.38414629C>A | NCI-TCGA |
rs776264072 | p.Arg661Gly | missense variant | - | NC_000008.11:g.38414626G>C | ExAC,gnomAD |
rs1257312391 | p.Arg661Gln | missense variant | - | NC_000008.11:g.38414625C>T | gnomAD |
VAR_080330 | p.Arg661_Arg822del | inframe_deletion | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
RCV000414726 | p.Val664Met | missense variant | - | NC_000008.11:g.38414617C>T | ClinVar |
rs1057518620 | p.Val664Met | missense variant | - | NC_000008.11:g.38414617C>T | - |
VAR_042203 | p.Val664Leu | Missense | - | - | UniProt |
rs1281881752 | p.Lys665Asn | missense variant | - | NC_000008.11:g.38414612C>A | TOPMed,gnomAD |
rs1427855487 | p.Lys665Arg | missense variant | - | NC_000008.11:g.38414613T>C | TOPMed |
rs1489129465 | p.Trp666Leu | missense variant | - | NC_000008.11:g.38414610C>A | gnomAD |
NCI-TCGA novel | p.Trp666Gly | missense variant | - | NC_000008.11:g.38414611A>C | NCI-TCGA |
RCV000710044 | p.Trp666Arg | missense variant | Hartsfield syndrome | NC_000008.11:g.38414611A>G | ClinVar |
VAR_017890 | p.Trp666Arg | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
NCI-TCGA novel | p.Ala668Thr | missense variant | - | NC_000008.11:g.38414605C>T | NCI-TCGA |
COSM3899995 | p.Glu670Gly | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38414598T>C | NCI-TCGA Cosmic |
RCV000043591 | p.Glu670Lys | missense variant | Hypogonadotropic hypogonadism 2 with anosmia | NC_000008.11:g.38414599C>T | ClinVar |
rs397515446 | p.Glu670Lys | missense variant | - | NC_000008.11:g.38414599C>T | - |
rs397515446 | p.Glu670Lys | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38414599C>T | UniProt,dbSNP |
VAR_069957 | p.Glu670Lys | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38414599C>T | UniProt |
VAR_069294 | p.Ala671Pro | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
RCV000493180 | p.Arg675Trp | missense variant | - | NC_000008.11:g.38414584G>A | ClinVar |
rs771078736 | p.Arg675Pro | missense variant | - | NC_000008.11:g.38414583C>G | ExAC,TOPMed |
rs771078736 | p.Arg675Gln | missense variant | - | NC_000008.11:g.38414583C>T | ExAC,TOPMed |
rs375611478 | p.Arg675Trp | missense variant | - | NC_000008.11:g.38414584G>A | ESP,ExAC,TOPMed,gnomAD |
COSM1099627 | p.Thr678Ser | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38414574G>C | NCI-TCGA Cosmic |
rs1435328508 | p.His679Tyr | missense variant | - | NC_000008.11:g.38414572G>A | TOPMed |
RCV000156950 | p.Gln680Ter | nonsense | Delayed puberty | NC_000008.11:g.38414569G>A | ClinVar |
rs1554547400 | p.Trp684Ter | stop gained | - | NC_000008.11:g.38414286C>T | - |
RCV000657784 | p.Trp684Ter | nonsense | - | NC_000008.11:g.38414286C>T | ClinVar |
VAR_031000 | p.Ser685Phe | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
rs727505376 | p.Gly687Arg | missense variant | - | NC_000008.11:g.38414279C>G | - |
RCV000156967 | p.Gly687Arg | missense variant | Hypogonadotropic hypogonadism 7 with or without anosmia (HH7) | NC_000008.11:g.38414279C>T | ClinVar |
rs727505376 | p.Gly687Arg | missense variant | - | NC_000008.11:g.38414279C>T | - |
RCV000503490 | p.Gly687Arg | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38414279C>G | ClinVar |
rs1057518060 | p.Val688Leu | missense variant | - | NC_000008.11:g.38414276C>G | - |
RCV000413066 | p.Val688Leu | missense variant | - | NC_000008.11:g.38414276C>G | ClinVar |
RCV000430948 | p.Trp691Cys | missense variant | - | NC_000008.11:g.38414265C>A | ClinVar |
rs1057524546 | p.Trp691Cys | missense variant | - | NC_000008.11:g.38414265C>A | - |
rs397515445 | p.Glu692Gly | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38414263T>C | UniProt,dbSNP |
VAR_069958 | p.Glu692Gly | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38414263T>C | UniProt |
rs397515445 | p.Glu692Gly | missense variant | - | NC_000008.11:g.38414263T>C | - |
RCV000043590 | p.Glu692Gly | missense variant | Hypogonadotropic hypogonadism 2 with anosmia | NC_000008.11:g.38414263T>C | ClinVar |
RCV000223865 | p.Glu692Lys | missense variant | Holoprosencephaly sequence (HPE) | NC_000008.11:g.38414264C>T | ClinVar |
rs876661335 | p.Glu692Lys | missense variant | - | NC_000008.11:g.38414264C>T | - |
rs763166714 | p.Ile693Val | missense variant | - | NC_000008.11:g.38414261T>C | ExAC,gnomAD |
VAR_031002 | p.Ile693Phe | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
RCV000119060 | p.Thr695Ile | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38414254G>A | ClinVar |
rs515726225 | p.Thr695Ile | missense variant | - | NC_000008.11:g.38414254G>A | - |
rs1352457632 | p.Tyr701Cys | missense variant | - | NC_000008.11:g.38414236T>C | gnomAD |
rs1366165565 | p.Gly703Ala | missense variant | - | NC_000008.11:g.38414230C>G | gnomAD |
rs768957161 | p.Gly703Ser | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38414231C>T | UniProt,dbSNP |
VAR_031004 | p.Gly703Ser | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38414231C>T | UniProt |
rs768957161 | p.Gly703Ser | missense variant | - | NC_000008.11:g.38414231C>T | ExAC,TOPMed,gnomAD |
VAR_031003 | p.Gly703Arg | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
rs745441616 | p.Lys714Arg | missense variant | - | NC_000008.11:g.38414197T>C | ExAC,TOPMed,gnomAD |
rs778281261 | p.Glu715Asp | missense variant | - | NC_000008.11:g.38414193C>A | ExAC,gnomAD |
NCI-TCGA novel | p.His717Tyr | missense variant | - | NC_000008.11:g.38414189G>A | NCI-TCGA |
NCI-TCGA novel | p.His717Asn | missense variant | - | NC_000008.11:g.38414189G>T | NCI-TCGA |
rs1376273429 | p.His717Arg | missense variant | - | NC_000008.11:g.38414188T>C | gnomAD |
rs1057520536 | p.Arg718Gly | missense variant | - | NC_000008.11:g.38414186G>C | - |
RCV000423621 | p.Arg718Gly | missense variant | - | NC_000008.11:g.38414186G>C | ClinVar |
rs1415925468 | p.Arg718His | missense variant | - | NC_000008.11:g.38414185C>T | gnomAD |
rs1085307879 | p.Met719Val | missense variant | - | NC_000008.11:g.38414183T>C | - |
RCV000490235 | p.Met719Val | missense variant | - | NC_000008.11:g.38414183T>C | ClinVar |
VAR_017891 | p.Met719Arg | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
NCI-TCGA novel | p.Asp720Asn | missense variant | - | NC_000008.11:g.38414180C>T | NCI-TCGA |
rs753372445 | p.Lys721Gln | missense variant | - | NC_000008.11:g.38414177T>G | ExAC,gnomAD |
rs121909642 | p.Pro722Ser | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38414174G>A | UniProt,dbSNP |
VAR_031006 | p.Pro722Ser | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38414174G>A | UniProt |
rs121909642 | p.Pro722Ser | missense variant | - | NC_000008.11:g.38414174G>A | - |
RCV000030937 | p.Pro722Ser | missense variant | Hypogonadotropic hypogonadism 2 with anosmia | NC_000008.11:g.38414174G>A | ClinVar |
NCI-TCGA novel | p.Pro722Leu | missense variant | - | NC_000008.11:g.38414173G>A | NCI-TCGA |
RCV000030930 | p.Pro722His | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38414173G>T | ClinVar |
rs267606805 | p.Pro722His | missense variant | - | NC_000008.11:g.38414173G>T | - |
rs755934643 | p.Ser723Asn | missense variant | - | NC_000008.11:g.38414170C>T | ExAC,gnomAD |
rs267606806 | p.Asn724Lys | missense variant | - | NC_000008.11:g.38414166G>C | ExAC,gnomAD |
RCV000030930 | p.Asn724Lys | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38414166G>C | ClinVar |
rs1190864622 | p.Asn724Tyr | missense variant | - | NC_000008.11:g.38414168T>A | gnomAD |
RCV000056313 | p.Cys725Tyr | missense variant | Hartsfield syndrome | NC_000008.11:g.38414164C>T | ClinVar |
rs398122945 | p.Cys725Tyr | missense variant | Hartsfield syndrome (HRTFDS) | NC_000008.11:g.38414164C>T | UniProt,dbSNP |
VAR_070856 | p.Cys725Tyr | missense variant | Hartsfield syndrome (HRTFDS) | NC_000008.11:g.38414164C>T | UniProt |
rs398122945 | p.Cys725Tyr | missense variant | Hartsfield syndrome (hrtfds) | NC_000008.11:g.38414164C>T | - |
rs1409446474 | p.Thr726Ala | missense variant | - | NC_000008.11:g.38414162T>C | TOPMed |
rs1257744746 | p.Asn727Ser | missense variant | - | NC_000008.11:g.38414158T>C | gnomAD |
rs759382055 | p.Glu728Lys | missense variant | - | NC_000008.11:g.38414156C>T | ExAC,gnomAD |
rs1044312216 | p.Met731Thr | missense variant | - | NC_000008.11:g.38414018A>G | TOPMed |
rs560927853 | p.Met731Val | missense variant | - | NC_000008.11:g.38414019T>C | 1000Genomes,gnomAD |
rs1329256283 | p.Arg734Trp | missense variant | - | NC_000008.11:g.38414010G>A | gnomAD |
rs760882547 | p.Arg734Gln | missense variant | - | NC_000008.11:g.38414009C>T | ExAC,TOPMed,gnomAD |
NCI-TCGA novel | p.Asp735His | missense variant | - | NC_000008.11:g.38414007C>G | NCI-TCGA |
rs1554546677 | p.Cys736Arg | missense variant | - | NC_000008.11:g.38414004A>G | - |
RCV000560918 | p.Cys736Arg | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38414004A>G | ClinVar |
rs727505377 | p.Trp737Arg | missense variant | - | NC_000008.11:g.38414001A>G | - |
RCV000156969 | p.Trp737Arg | missense variant | Hypogonadotropic hypogonadism 7 with or without anosmia (HH7) | NC_000008.11:g.38414001A>G | ClinVar |
rs1166216167 | p.Ala739Thr | missense variant | - | NC_000008.11:g.38413995C>T | gnomAD |
rs1444167285 | p.Ala739Val | missense variant | - | NC_000008.11:g.38413994G>A | gnomAD |
COSM3899987 | p.Val740Met | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000008.11:g.38413992C>T | NCI-TCGA Cosmic |
rs1412615365 | p.Pro741His | missense variant | - | NC_000008.11:g.38413988G>T | gnomAD |
VAR_031008 | p.Pro745Ser | Missense | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950] | - | UniProt |
rs760108543 | p.Thr746Asn | missense variant | - | NC_000008.11:g.38413973G>T | ExAC,gnomAD |
NCI-TCGA novel | p.Val751Met | missense variant | - | NC_000008.11:g.38413959C>T | NCI-TCGA |
NCI-TCGA novel | p.Asp755Ala | missense variant | - | NC_000008.11:g.38413946T>G | NCI-TCGA |
rs374473310 | p.Arg756His | missense variant | - | NC_000008.11:g.38413943C>T | ESP,ExAC,TOPMed,gnomAD |
rs1219463859 | p.Arg756Cys | missense variant | - | NC_000008.11:g.38413944G>A | gnomAD |
rs527606454 | p.Val758Met | missense variant | - | NC_000008.11:g.38413938C>T | 1000Genomes,ExAC,TOPMed,gnomAD |
rs1210419471 | p.Ala759Val | missense variant | - | NC_000008.11:g.38413934G>A | TOPMed |
rs746786094 | p.Asn763Lys | missense variant | - | NC_000008.11:g.38413921G>C | ExAC,gnomAD |
rs121909643 | p.Gln764His | missense variant | - | NC_000008.11:g.38413918C>G | TOPMed |
RCV000030938 | p.Gln764His | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38413918C>A | ClinVar |
rs121909643 | p.Gln764His | missense variant | - | NC_000008.11:g.38413918C>A | TOPMed |
rs1396211501 | p.Leu767Met | missense variant | - | NC_000008.11:g.38413798G>T | gnomAD |
rs121909644 | p.Asp768Asn | missense variant | - | NC_000008.11:g.38413795C>T | TOPMed |
RCV000030939 | p.Asp768Tyr | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38413795C>A | ClinVar |
rs121909644 | p.Asp768Tyr | missense variant | - | NC_000008.11:g.38413795C>A | TOPMed |
rs121909644 | p.Asp768Tyr | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38413795C>A | UniProt,dbSNP |
VAR_069959 | p.Asp768Tyr | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38413795C>A | UniProt |
rs2956723 | p.Leu769Val | missense variant | - | NC_000008.11:g.38413792G>C | UniProt,dbSNP |
VAR_031009 | p.Leu769Val | missense variant | - | NC_000008.11:g.38413792G>C | UniProt |
rs2956723 | p.Leu769Val | missense variant | - | NC_000008.11:g.38413792G>C | - |
rs751937328 | p.Ser770Cys | missense variant | - | NC_000008.11:g.38413788G>C | ExAC,gnomAD |
rs751937328 | p.Ser770Phe | missense variant | - | NC_000008.11:g.38413788G>A | ExAC,gnomAD |
rs1301403995 | p.Met771Val | missense variant | - | NC_000008.11:g.38413786T>C | gnomAD |
rs1466028968 | p.Met771Ile | missense variant | - | NC_000008.11:g.38413784C>T | TOPMed,gnomAD |
rs56234888 | p.Pro772Ser | missense variant | - | NC_000008.11:g.38413783G>A | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
RCV000316400 | p.Pro772Ser | missense variant | Osteoglophonic dysplasia (OGD) | NC_000008.11:g.38413783G>A | ClinVar |
RCV000263686 | p.Pro772Ser | missense variant | Pfeiffer syndrome (ACS5) | NC_000008.11:g.38413783G>A | ClinVar |
RCV000322415 | p.Pro772Ser | missense variant | Hypogonadism with anosmia (KS) | NC_000008.11:g.38413783G>A | ClinVar |
RCV000356059 | p.Pro772Ser | missense variant | - | NC_000008.11:g.38413783G>A | ClinVar |
RCV000264893 | p.Pro772Ser | missense variant | Nonsyndromic Trigonocephaly | NC_000008.11:g.38413783G>A | ClinVar |
RCV000677340 | p.Pro772Ser | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38413783G>A | ClinVar |
rs56234888 | p.Pro772Thr | missense variant | - | NC_000008.11:g.38413783G>T | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
rs1232665126 | p.Gln775Glu | missense variant | - | NC_000008.11:g.38413774G>C | TOPMed |
rs1172958596 | p.Gln775His | missense variant | - | NC_000008.11:g.38413772C>G | gnomAD |
rs1330993385 | p.Tyr776Ter | stop gained | - | NC_000008.11:g.38413769G>C | TOPMed |
rs1307564234 | p.Tyr776Ser | missense variant | - | NC_000008.11:g.38413770T>G | gnomAD |
rs1330993385 | p.Tyr776Ter | stop gained | - | NC_000008.11:g.38413769G>T | TOPMed |
rs1213419262 | p.Ser777Phe | missense variant | - | NC_000008.11:g.38413767G>A | TOPMed |
rs1483382491 | p.Pro778Leu | missense variant | - | NC_000008.11:g.38413764G>A | TOPMed |
rs764873744 | p.Phe780Ser | missense variant | - | NC_000008.11:g.38413758A>G | ExAC |
rs776189467 | p.Asp782Asn | missense variant | - | NC_000008.11:g.38413753C>T | ExAC,TOPMed,gnomAD |
rs746602135 | p.Arg784Gln | missense variant | - | NC_000008.11:g.38413746C>T | ExAC,TOPMed,gnomAD |
rs377149398 | p.Arg784Trp | missense variant | - | NC_000008.11:g.38413747G>A | ESP,gnomAD |
rs775161322 | p.Ser786Cys | missense variant | - | NC_000008.11:g.38413740G>C | ExAC,gnomAD |
rs555706876 | p.Thr787Met | missense variant | - | NC_000008.11:g.38413737G>A | 1000Genomes,ExAC,TOPMed,gnomAD |
NCI-TCGA novel | p.Ser789Cys | missense variant | - | NC_000008.11:g.38413731G>C | NCI-TCGA |
rs1421199406 | p.Ser790Leu | missense variant | - | NC_000008.11:g.38413728G>A | TOPMed |
NCI-TCGA novel | p.Gly791Val | missense variant | - | NC_000008.11:g.38413725C>A | NCI-TCGA |
rs989394574 | p.Asp793Asn | missense variant | - | NC_000008.11:g.38413720C>T | TOPMed,gnomAD |
rs781328162 | p.Val795Ile | missense variant | - | NC_000008.11:g.38413714C>T | ExAC,TOPMed,gnomAD |
rs781328162 | p.Val795Ile | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38413714C>T | UniProt,dbSNP |
VAR_031010 | p.Val795Ile | missense variant | Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) | NC_000008.11:g.38413714C>T | UniProt |
NCI-TCGA novel | p.His798Tyr | missense variant | - | NC_000008.11:g.38413705G>A | NCI-TCGA |
rs755160898 | p.His798Arg | missense variant | - | NC_000008.11:g.38413704T>C | ExAC,TOPMed,gnomAD |
rs377620009 | p.Pro800Leu | missense variant | - | NC_000008.11:g.38413698G>A | ESP,ExAC,TOPMed,gnomAD |
rs765900637 | p.Glu803Ter | stop gained | - | NC_000008.11:g.38413690C>A | ExAC,TOPMed,gnomAD |
rs765900637 | p.Glu803Lys | missense variant | - | NC_000008.11:g.38413690C>T | ExAC,TOPMed,gnomAD |
rs1238519686 | p.Glu804Lys | missense variant | - | NC_000008.11:g.38413687C>T | gnomAD |
rs1456342214 | p.Pro805Ala | missense variant | - | NC_000008.11:g.38413684G>C | TOPMed,gnomAD |
rs1456342214 | p.Pro805Ser | missense variant | - | NC_000008.11:g.38413684G>A | TOPMed,gnomAD |
rs763600740 | p.Cys806Ter | stop gained | - | NC_000008.11:g.38413679G>T | ExAC,gnomAD |
rs753288703 | p.Cys806Tyr | missense variant | - | NC_000008.11:g.38413680C>T | ExAC,gnomAD |
rs771680156 | p.Arg809Gln | missense variant | - | NC_000008.11:g.38413671C>T | ExAC,TOPMed,gnomAD |
rs775166971 | p.Arg809Ter | stop gained | - | NC_000008.11:g.38413672G>A | ExAC,TOPMed,gnomAD |
rs759376422 | p.His810Tyr | missense variant | - | NC_000008.11:g.38413669G>A | ExAC,TOPMed,gnomAD |
rs759376422 | p.His810Asn | missense variant | - | NC_000008.11:g.38413669G>T | ExAC,TOPMed,gnomAD |
rs774120844 | p.Pro811Arg | missense variant | - | NC_000008.11:g.38413665G>C | ExAC,gnomAD |
rs1324331483 | p.Pro811Ala | missense variant | - | NC_000008.11:g.38413666G>C | TOPMed,gnomAD |
rs749184176 | p.Gln813His | missense variant | - | NC_000008.11:g.38413658C>A | ExAC,TOPMed,gnomAD |
rs1162921288 | p.Asn816His | missense variant | - | NC_000008.11:g.38413651T>G | gnomAD |
rs17182456 | p.Gly818Arg | missense variant | - | NC_000008.11:g.38413645C>T | TOPMed,gnomAD |
rs1437821654 | p.Gly818Glu | missense variant | - | NC_000008.11:g.38413644C>T | gnomAD |
rs768736835 | p.Arg821Cys | missense variant | - | NC_000008.11:g.38413636G>A | ExAC,TOPMed,gnomAD |
rs747228916 | p.Arg821His | missense variant | - | NC_000008.11:g.38413635C>T | ExAC,gnomAD |
RCV000310867 | p.Arg822His | missense variant | Nonsyndromic Trigonocephaly | NC_000008.11:g.38413632C>T | ClinVar |
RCV000361960 | p.Arg822His | missense variant | Hypogonadism with anosmia (KS) | NC_000008.11:g.38413632C>T | ClinVar |
RCV000395481 | p.Arg822His | missense variant | Pfeiffer syndrome (ACS5) | NC_000008.11:g.38413632C>T | ClinVar |
RCV000363279 | p.Arg822His | missense variant | Osteoglophonic dysplasia (OGD) | NC_000008.11:g.38413632C>T | ClinVar |
rs17182463 | p.Arg822Cys | missense variant | - | NC_000008.11:g.38413633G>A | ESP,ExAC,TOPMed,gnomAD |
rs758677681 | p.Arg822His | missense variant | - | NC_000008.11:g.38413632C>T | ExAC,TOPMed,gnomAD |
RCV000304983 | p.Arg822His | missense variant | - | NC_000008.11:g.38413632C>T | ClinVar |
RCV000757293 | p.Arg822His | missense variant | - | NC_000008.11:g.38413632C>T | ClinVar |
RCV000644522 | p.Arg822Cys | missense variant | Kallmann syndrome 2 (KAL2) | NC_000008.11:g.38413633G>A | ClinVar |
Disease ID | Disease Name | Disease Type | Source |
---|---|---|---|
C0000768 | Congenital Abnormality | group | BEFREE |
C0000889 | Acanthosis Nigricans | disease | BEFREE |
C0001193 | Apert syndrome | disease | BEFREE |
C0001339 | Acute pancreatitis | disease | BEFREE |
C0001418 | Adenocarcinoma | group | BEFREE;LHGDN |
C0002170 | Alopecia | disease | HPO |
C0002793 | Anaplasia | disease | BEFREE |
C0003126 | Anosmia | phenotype | BEFREE;HPO |
C0003467 | Anxiety | disease | HPO |
C0003537 | Aphasia | disease | HPO |
C0003803 | Arnold Chiari Malformation | disease | HPO |
C0003850 | Arteriosclerosis | disease | BEFREE |
C0003873 | Rheumatoid Arthritis | disease | BEFREE |
C0004114 | Astrocytoma | disease | BEFREE;CLINVAR;CTD_human |
C0004153 | Atherosclerosis | disease | BEFREE |
C0005586 | Bipolar Disorder | disease | BEFREE;PSYGENET |
C0005684 | Malignant neoplasm of urinary bladder | disease | BEFREE |
C0005695 | Bladder Neoplasm | group | BEFREE;LHGDN |
C0005699 | Blast Phase | disease | BEFREE |
C0005745 | Blepharoptosis | disease | HPO |
C0005937 | Bone Cysts | phenotype | HPO |
C0005967 | Bone neoplasms | group | HPO |
C0006118 | Brain Neoplasms | group | BEFREE |
C0006142 | Malignant neoplasm of breast | disease | BEFREE;CGI;CTD_human |
C0006826 | Malignant Neoplasms | group | BEFREE;CGI |
C0007112 | Adenocarcinoma of prostate | disease | BEFREE |
C0007115 | Malignant neoplasm of thyroid | disease | BEFREE |
C0007120 | Bronchioloalveolar Adenocarcinoma | disease | BEFREE |
C0007124 | Noninfiltrating Intraductal Carcinoma | disease | BEFREE |
C0007131 | Non-Small Cell Lung Carcinoma | disease | BEFREE;CTD_human |
C0007137 | Squamous cell carcinoma | disease | BEFREE;CTD_human;LHGDN |
C0007138 | Carcinoma, Transitional Cell | disease | BEFREE |
C0007762 | Cerebellar Neoplasms | group | BEFREE |
C0007787 | Transient Ischemic Attack | disease | RGD |
C0008297 | Choanal Atresia | disease | HPO |
C0008479 | Chondrosarcoma | disease | BEFREE |
C0008487 | Chordoma | disease | BEFREE |
C0008497 | Choriocarcinoma | disease | BEFREE |
C0008626 | Congenital chromosomal disease | group | BEFREE |
C0008924 | Cleft upper lip | disease | BEFREE;CTD_human;HPO;LHGDN |
C0008925 | Cleft Palate | disease | BEFREE;CTD_human;LHGDN |
C0009402 | Colorectal Carcinoma | disease | BEFREE |
C0009404 | Colorectal Neoplasms | group | LHGDN |
C0010038 | Corneal Opacity | phenotype | HPO |
C0010054 | Coronary Arteriosclerosis | disease | BEFREE |
C0010278 | Craniosynostosis | disease | BEFREE;CTD_human;GENOMICS_ENGLAND;HPO;LHGDN |
C0010417 | Cryptorchidism | disease | BEFREE;HPO |
C0010964 | Dandy-Walker Syndrome | disease | HPO |
C0011263 | Multi-infarct dementia | disease | RGD |
C0011269 | Dementia, Vascular | disease | RGD |
C0011303 | Demyelinating Diseases | group | BEFREE |
C0011570 | Mental Depression | disease | PSYGENET |
C0011573 | Endogenous depression | disease | CTD_human |
C0011581 | Depressive disorder | disease | CTD_human;HPO;PSYGENET |
C0011848 | Diabetes Insipidus | disease | HPO |
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | disease | BEFREE |
C0013336 | Dwarfism | disease | BEFREE;HPO |
C0013404 | Dyspnea | phenotype | HPO |
C0013528 | Echolalia | phenotype | HPO |
C0014065 | Congenital cerebral hernia | disease | HPO |
C0014457 | Eosinophilia | disease | BEFREE |
C0014474 | Ependymoma | disease | BEFREE |
C0014544 | Epilepsy | disease | HPO |
C0015300 | Exophthalmos | disease | HPO |
C0015934 | Fetal Growth Retardation | phenotype | HPO |
C0015967 | Fever | phenotype | BEFREE |
C0017636 | Glioblastoma | disease | BEFREE;CLINVAR;LHGDN |
C0017638 | Glioma | disease | BEFREE;CTD_human |
C0018418 | Gynecomastia | disease | HPO |
C0018671 | Head and Neck Neoplasms | group | CGI |
C0018784 | Sensorineural Hearing Loss (disorder) | disease | BEFREE;HPO |
C0018798 | Congenital Heart Defects | group | HPO |
C0018817 | Atrial Septal Defects | group | HPO |
C0018818 | Ventricular Septal Defects | group | HPO |
C0018939 | Hematological Disease | group | BEFREE |
C0019294 | Hernia, Inguinal | phenotype | HPO |
C0020255 | Hydrocephalus | disease | GENOMICS_ENGLAND;HPO |
C0020295 | Hydronephrosis | disease | HPO |
C0020488 | Hypernatremia | disease | HPO |
C0020503 | Hyperparathyroidism, Secondary | disease | BEFREE |
C0020534 | Orbital separation excessive | phenotype | HPO |
C0020542 | Pulmonary Hypertension | phenotype | RGD |
C0020608 | Hypodontia | disease | BEFREE;ORPHANET |
C0020619 | Hypogonadism | disease | LHGDN |
C0021296 | Infant, Small for Gestational Age | phenotype | HPO |
C0021400 | Influenza | disease | BEFREE |
C0022735 | Klinefelter Syndrome | disease | BEFREE |
C0023012 | Language Delay | phenotype | HPO |
C0023267 | Fibroid Tumor | group | LHGDN |
C0023418 | leukemia | disease | BEFREE |
C0023448 | Lymphoid leukemia | disease | BEFREE |
C0023449 | Acute lymphocytic leukemia | disease | BEFREE |
C0023467 | Leukemia, Myelocytic, Acute | disease | BEFREE |
C0023473 | Myeloid Leukemia, Chronic | disease | BEFREE |
C0023479 | Acute myelomonocytic leukemia | disease | BEFREE |
C0023480 | Leukemia, Myelomonocytic, Chronic | disease | BEFREE |
C0023487 | Acute Promyelocytic Leukemia | disease | BEFREE |
C0023787 | Lipodystrophy | disease | HPO |
C0023798 | Lipoma | disease | HPO |
C0023801 | Lipomatosis | disease | HPO |
C0023903 | Liver neoplasms | group | BEFREE |
C0024121 | Lung Neoplasms | group | CTD_human |
C0024299 | Lymphoma | group | BEFREE |
C0024305 | Lymphoma, Non-Hodgkin | disease | BEFREE |
C0024623 | Malignant neoplasm of stomach | disease | BEFREE |
C0025037 | Meckel Diverticulum | disease | HPO |
C0025149 | Medulloblastoma | disease | CLINVAR |
C0025193 | Melancholia | disease | CTD_human |
C0025202 | melanoma | disease | BEFREE;LHGDN |
C0025286 | Meningioma | disease | BEFREE |
C0025362 | Mental Retardation | disease | HPO |
C0025500 | Mesothelioma | disease | BEFREE |
C0025990 | Micrognathism | disease | HPO |
C0026010 | Microphthalmos | disease | HPO |
C0026636 | Mouth Diseases | group | RGD |
C0026764 | Multiple Myeloma | disease | BEFREE |
C0026837 | Muscle Rigidity | phenotype | HPO |
C0026838 | Muscle Spasticity | phenotype | HPO |
C0026884 | Mutism | phenotype | HPO |
C0026996 | Myeloid hyperplasia | disease | BEFREE |
C0027022 | Myeloproliferative disease | group | BEFREE;CTD_human;LHGDN |
C0027424 | Nasal congestion (finding) | phenotype | HPO |
C0027429 | Nasal obstruction present finding | phenotype | HPO |
C0027627 | Neoplasm Metastasis | phenotype | BEFREE;LHGDN |
C0027651 | Neoplasms | group | BEFREE;CLINVAR |
C0027819 | Neuroblastoma | group | BEFREE;CLINVAR |
C0028738 | Nystagmus | disease | HPO |
C0028754 | Obesity | disease | BEFREE;RGD |
C0028945 | oligodendroglioma | disease | BEFREE |
C0029408 | Degenerative polyarthritis | disease | BEFREE |
C0029434 | Osteogenesis Imperfecta | disease | GENOMICS_ENGLAND |
C0029442 | Osteomalacia | disease | BEFREE |
C0029453 | Osteopenia | disease | HPO |
C0029456 | Osteoporosis | disease | BEFREE;HPO |
C0029463 | Osteosarcoma | disease | BEFREE |
C0029882 | Otitis Media | disease | MGD |
C0029925 | Ovarian Carcinoma | disease | BEFREE |
C0030044 | Acrocephaly | disease | CTD_human |
C0030421 | Paraganglioma | disease | BEFREE |
C0032002 | Pituitary Diseases | group | BEFREE |
C0033578 | Prostatic Neoplasms | group | LHGDN |
C0033785 | Pseudarthrosis | phenotype | HPO |
C0034012 | Delayed Puberty | phenotype | CLINVAR;HPO;LHGDN |
C0035229 | Respiratory Insufficiency | phenotype | HPO |
C0035305 | Retinal Detachment | disease | RGD |
C0035309 | Retinal Diseases | group | HPO |
C0035335 | Retinoblastoma | disease | BEFREE |
C0035412 | Rhabdomyosarcoma | disease | BEFREE;LHGDN |
C0035579 | Rickets | disease | BEFREE |
C0036220 | Kaposi Sarcoma | disease | BEFREE |
C0036341 | Schizophrenia | disease | BEFREE;CTD_human;GWASCAT |
C0036572 | Seizures | phenotype | HPO |
C0038379 | Strabismus | disease | HPO |
C0039075 | Syndactyly | disease | BEFREE;HPO |
C0039273 | Talipes cavus | phenotype | BEFREE |
C0039538 | Teratoma | disease | BEFREE |
C0040034 | Thrombocytopenia | phenotype | BEFREE |
C0040433 | Tooth Crowding | phenotype | HPO |
C0040458 | Unerupted tooth | phenotype | HPO |
C0040962 | Tricuspid Valve Prolapse | disease | HPO |
C0041696 | Unipolar Depression | disease | CTD_human;PSYGENET |
C0042769 | Virus Diseases | group | BEFREE |
C0042798 | Low Vision | disease | HPO |
C0043325 | Xanthomatosis | disease | HPO |
C0078981 | Arachnoid Cysts | disease | HPO |
C0079541 | Holoprosencephaly | disease | CLINVAR;GENOMICS_ENGLAND |
C0079731 | B-Cell Lymphomas | group | BEFREE |
C0079748 | Precursor cell lymphoblastic lymphoma | disease | BEFREE |
C0079772 | T-Cell Lymphoma | disease | BEFREE |
C0080233 | Tooth Loss | phenotype | BEFREE |
C0085136 | Central Nervous System Neoplasms | group | BEFREE |
C0085669 | Acute leukemia | disease | BEFREE |
C0086133 | Depressive Syndrome | disease | CTD_human |
C0149782 | Squamous cell carcinoma of lung | disease | BEFREE;CGI |
C0149925 | Small cell carcinoma of lung | disease | BEFREE;CTD_human |
C0149940 | Sciatic Neuropathy | disease | RGD |
C0151721 | Testicular hypogonadism | disease | HPO |
C0151811 | Subcutaneous nodule | phenotype | HPO |
C0151825 | Bone pain | phenotype | BEFREE |
C0151846 | Periosteal Disorder | disease | BEFREE |
C0152013 | Adenocarcinoma of lung (disorder) | disease | BEFREE |
C0152018 | Esophageal carcinoma | disease | BEFREE |
C0152427 | Polydactyly | disease | GENOMICS_ENGLAND |
C0153633 | Malignant neoplasm of brain | disease | BEFREE |
C0153690 | Secondary malignant neoplasm of bone | disease | BEFREE |
C0155728 | Other specified transient cerebral ischemias | disease | RGD |
C0158646 | Cleft palate with cleft lip | disease | BEFREE |
C0162809 | Kallmann Syndrome | disease | BEFREE;CTD_human;LHGDN;ORPHANET |
C0175754 | Agenesis of corpus callosum | disease | HPO |
C0178874 | Tumor Progression | phenotype | BEFREE |
C0205768 | Subependymal Giant Cell Astrocytoma | disease | CTD_human |
C0206141 | Idiopathic Hypereosinophilic Syndrome | disease | BEFREE |
C0206623 | Adenosquamous carcinoma | disease | BEFREE |
C0206655 | Alveolar rhabdomyosarcoma | disease | BEFREE |
C0206684 | Sebaceous Adenocarcinoma | disease | BEFREE |
C0206692 | Carcinoma, Lobular | disease | BEFREE |
C0206698 | Cholangiocarcinoma | disease | BEFREE |
C0206704 | Carcinoma, Large Cell | disease | BEFREE |
C0206721 | Inverted Papilloma | disease | BEFREE |
C0206726 | gliosarcoma | disease | ORPHANET |
C0206733 | Strawberry nevus of skin | disease | HPO |
C0220633 | Uveal melanoma | disease | BEFREE |
C0220650 | Metastatic malignant neoplasm to brain | disease | BEFREE |
C0220658 | Pfeiffer Syndrome | disease | BEFREE;MGD;UNIPROT |
C0220668 | Congenital contractural arachnodactyly | disease | BEFREE |
C0220748 | Cartilage-hair hypoplasia | disease | BEFREE |
C0221170 | Muscular stiffness | phenotype | HPO |
C0221182 | Chordee | disease | HPO |
C0221204 | Lytic lesion | phenotype | HPO |
C0221209 | Pelvic kidney | disease | HPO |
C0221238 | Mesangial proliferative glomerulonephritis | disease | RGD |
C0221352 | Syndactyly of fingers | disease | HPO |
C0221354 | Frontal bossing | disease | HPO |
C0221356 | Brachycephaly | disease | CTD_human;HPO |
C0221373 | Claw hand | disease | HPO |
C0221775 | Lumbar disc disease | disease | BEFREE |
C0231246 | Failure to gain weight | phenotype | HPO |
C0232939 | Primary physiologic amenorrhea | disease | HPO |
C0232940 | Secondary physiologic amenorrhea | disease | HPO |
C0233715 | Speech impairment | phenotype | HPO |
C0234362 | Synkinesis | phenotype | BEFREE |
C0235752 | Port-Wine Stain | disease | HPO |
C0235942 | Abnormality of the skull | phenotype | HPO |
C0235946 | Cerebral atrophy | disease | HPO |
C0235974 | Pancreatic carcinoma | disease | BEFREE |
C0238198 | Gastrointestinal Stromal Tumors | group | BEFREE |
C0239234 | Low set ears | phenotype | HPO |
C0239399 | Short extremities | phenotype | HPO |
C0239676 | High forehead | phenotype | HPO |
C0240063 | Coloboma of iris | phenotype | HPO |
C0240310 | Hypoplasia of the maxilla | disease | HPO |
C0240340 | Microdontia (disorder) | disease | HPO |
C0240635 | Byzanthine arch palate | disease | BEFREE;HPO |
C0241210 | Speech Delay | phenotype | HPO |
C0241355 | Small testicle | phenotype | HPO |
C0242343 | Panhypopituitarism | disease | BEFREE |
C0242350 | Erectile dysfunction | disease | HPO |
C0242379 | Malignant neoplasm of lung | disease | BEFREE;CTD_human |
C0259783 | mixed gliomas | disease | CTD_human |
C0262584 | Carcinoma, Small Cell | disease | BEFREE |
C0263661 | Disorder of skeletal system | group | BEFREE |
C0263662 | Disseminated eosinophilic collagen disease | disease | BEFREE |
C0263874 | Degeneration of lumbar intervertebral disc | disease | BEFREE |
C0264142 | Spade-like hand | disease | HPO |
C0264353 | Bronchomalacia | disease | HPO |
C0265534 | Scaphycephaly | disease | CTD_human |
C0265535 | Trigonocephaly | disease | BEFREE;CTD_human;HPO;ORPHANET |
C0265554 | Ectrodactyly | disease | BEFREE;HPO |
C0265660 | Syndactyly of the toes | disease | HPO |
C0266013 | Congenital hypoplasia of breast | disease | HPO |
C0266294 | Unilateral agenesis of kidney | disease | BEFREE |
C0266399 | Infantile uterus | disease | HPO |
C0266435 | Congenital hypoplasia of penis | disease | BEFREE;HPO |
C0266470 | Cerebellar Hypoplasia | disease | HPO |
C0266617 | Congenital anomaly of face | group | BEFREE |
C0269011 | Increased size of penis | phenotype | HPO |
C0270685 | Cerebral calcification | phenotype | HPO |
C0270824 | Visual seizure | disease | RGD |
C0271578 | Female hypogonadism syndrome | disease | HPO |
C0271623 | Hypogonadotropic hypogonadism | disease | BEFREE;HPO |
C0278488 | Carcinoma breast stage IV | disease | BEFREE |
C0278493 | Breast cancer recurrent | disease | BEFREE |
C0278601 | Inflammatory Breast Carcinoma | disease | BEFREE |
C0278701 | Gastric Adenocarcinoma | disease | BEFREE;CLINVAR |
C0278996 | Malignant Head and Neck Neoplasm | disease | CGI |
C0279070 | Adult Oligodendroglioma | disease | BEFREE |
C0279565 | Invasive Lobular Breast Carcinoma | disease | BEFREE |
C0279626 | Squamous cell carcinoma of esophagus | disease | BEFREE |
C0279680 | Transitional cell carcinoma of bladder | disease | CLINVAR |
C0280100 | Solid Neoplasm | phenotype | BEFREE |
C0280217 | stage, non-small cell lung cancer | disease | BEFREE |
C0280218 | stage, bladder cancer | phenotype | BEFREE |
C0280324 | Laryngeal Squamous Cell Carcinoma | disease | BEFREE |
C0280475 | Childhood Oligodendroglioma | disease | BEFREE |
C0280725 | Adult Cholangiocarcinoma | disease | BEFREE |
C0280783 | Juvenile Pilocytic Astrocytoma | disease | CTD_human |
C0280785 | Diffuse Astrocytoma | disease | CTD_human |
C0281361 | Adenocarcinoma of pancreas | disease | BEFREE |
C0282126 | Depression, Neurotic | disease | CTD_human |
C0302501 | Mandibular hyperplasia | phenotype | HPO |
C0334579 | Anaplastic astrocytoma | disease | CTD_human |
C0334580 | Protoplasmic astrocytoma | disease | CTD_human |
C0334581 | Gemistocytic astrocytoma | disease | CTD_human |
C0334582 | Fibrillary Astrocytoma | disease | CTD_human |
C0334583 | Pilocytic Astrocytoma | disease | BEFREE;CTD_human;ORPHANET |
C0334588 | Giant Cell Glioblastoma | disease | ORPHANET |
C0338070 | Childhood Cerebral Astrocytoma | disease | CTD_human |
C0338503 | Septo-Optic Dysplasia | disease | BEFREE;HPO;ORPHANET |
C0340375 | Subaortic stenosis | disease | HPO |
C0341862 | Hypothalamic amenorrhea | disease | BEFREE |
C0342384 | Idiopathic hypogonadotropic hypogonadism | disease | BEFREE;CLINVAR;GENOMICS_ENGLAND |
C0343641 | Human papilloma virus infection | disease | BEFREE |
C0344482 | Hypoplasia of corpus callosum | disease | HPO |
C0344539 | Hypoplasia of iris | disease | HPO |
C0345030 | Peripheral pulmonary artery stenosis | disease | HPO |
C0345958 | Large cell carcinoma of lung | disease | UNIPROT |
C0346421 | Chronic eosinophilic leukemia | disease | BEFREE |
C0346647 | Malignant neoplasm of pancreas | disease | BEFREE |
C0349588 | Short stature | phenotype | HPO |
C0375206 | Hemiplegia/hemiparesis | disease | HPO |
C0376356 | Premenstrual Tension | disease | BEFREE |
C0376358 | Malignant neoplasm of prostate | disease | BEFREE |
C0376545 | Hematologic Neoplasms | group | BEFREE |
C0376634 | Craniofacial Abnormalities | group | CTD_human |
C0391826 | Lhermitte-Duclos disease | disease | BEFREE |
C0399352 | Developmental absence of tooth | disease | BEFREE |
C0399526 | Class III malocclusion | disease | HPO |
C0406612 | Encephalocraniocutaneous lipomatosis | disease | BEFREE;CLINVAR;CTD_human;ORPHANET;UNIPROT |
C0409477 | Ankylosis of the elbow joint | disease | HPO |
C0423110 | Downward slant of palpebral fissure | phenotype | HPO |
C0423113 | Telecanthus | phenotype | HPO |
C0423903 | Low intelligence | phenotype | HPO |
C0424688 | Small head | phenotype | HPO |
C0424711 | Orbital separation diminished | phenotype | HPO |
C0426414 | Small nose | phenotype | HPO |
C0426421 | Wide nose | phenotype | HPO |
C0426891 | Broad thumbs | phenotype | HPO |
C0431362 | Lobar Holoprosencephaly | disease | CLINVAR;HPO;ORPHANET |
C0431371 | Absence of septum pellucidum | disease | HPO |
C0431380 | Cortical Dysplasia | disease | HPO |
C0431447 | Synophrys | disease | HPO |
C0431478 | Posteriorly rotated ear | disease | HPO |
C0432040 | Simple syndactyly of toes, first web space | disease | HPO |
C0432072 | Dysmorphic features | disease | BEFREE |
C0432122 | Interfrontal craniofaciosynostosis | disease | BEFREE;UNIPROT |
C0432123 | Sagittal craniosynostosis | disease | BEFREE |
C0432149 | Lumbar hemivertebra | disease | HPO |
C0432283 | Osteoglophonic dwarfism | disease | BEFREE;CLINVAR;CTD_human;ORPHANET;UNIPROT |
C0454455 | Mirror movements disorder | disease | HPO |
C0454644 | Delayed speech and language development | phenotype | HPO |
C0476273 | Respiratory distress | phenotype | HPO |
C0494165 | Secondary malignant neoplasm of liver | disease | BEFREE |
C0496897 | Benign neoplasm of eye, unspecified | disease | HPO |
C0496956 | Neoplasm of uncertain or unknown behavior of breast | disease | CGI |
C0520927 | Decreased fertility | phenotype | HPO |
C0521525 | Short neck | phenotype | HPO |
C0521573 | Coloboma of eyelid | phenotype | HPO |
C0521719 | Clouding of corneal stroma | disease | HPO |
C0541764 | Delayed bone age | phenotype | HPO |
C0542519 | Congenital absence of kidney | disease | BEFREE |
C0546297 | Hallux Varus | phenotype | HPO |
C0546837 | Malignant neoplasm of esophagus | disease | BEFREE |
C0547065 | Mixed oligoastrocytoma | disease | CTD_human |
C0549473 | Thyroid carcinoma | disease | BEFREE |
C0553580 | Ewings sarcoma | disease | BEFREE |
C0555198 | Malignant Glioma | disease | CTD_human |
C0557874 | Global developmental delay | disease | HPO |
C0584837 | Choanal stenosis | phenotype | HPO |
C0585442 | Osteosarcoma of bone | disease | BEFREE |
C0596263 | Carcinogenesis | phenotype | BEFREE |
C0598766 | Leukemogenesis | disease | BEFREE |
C0598798 | Lymphoid neoplasm | disease | BEFREE |
C0600139 | Prostate carcinoma | disease | BEFREE |
C0677865 | Brain Stem Glioma | disease | CLINVAR |
C0677898 | invasive cancer | phenotype | BEFREE |
C0678222 | Breast Carcinoma | disease | BEFREE;CGI;CTD_human |
C0678230 | Congenital Epicanthus | disease | HPO |
C0678236 | Rare Diseases | group | BEFREE |
C0684249 | Carcinoma of lung | disease | BEFREE |
C0685840 | Congenital hypoplasia of ovary | disease | HPO |
C0686619 | Secondary malignant neoplasm of lymph node | disease | BEFREE |
C0687150 | Parathyroid Gland Adenocarcinoma | disease | BEFREE |
C0699791 | Stomach Carcinoma | disease | BEFREE |
C0699885 | Carcinoma of bladder | disease | BEFREE |
C0700095 | Central neuroblastoma | disease | BEFREE |
C0728829 | Congenital pes cavus | disease | BEFREE |
C0745730 | Multiple lipomata | disease | HPO |
C0746926 | Multiple, subcutaneous nodules | disease | HPO |
C0747078 | Generalized osteopenia | disease | HPO |
C0750935 | Cerebral Astrocytoma | disease | CTD_human |
C0750936 | Intracranial Astrocytoma | disease | CTD_human |
C0751396 | Well Differentiated Oligodendroglioma | disease | BEFREE |
C0751617 | Semilobar Holoprosencephaly | disease | CLINVAR;ORPHANET |
C0751688 | Malignant Squamous Cell Neoplasm | disease | BEFREE |
C0795690 | Congenital omphalocele | disease | HPO |
C0795998 | JACKSON-WEISS SYNDROME | disease | CLINVAR;CTD_human;UNIPROT |
C0812413 | Malignant Pleural Mesothelioma | disease | BEFREE |
C0814161 | impaired motor coordination | phenotype | BEFREE |
C0848558 | Hypospadias | group | HPO |
C0851887 | Adenoviral infections | group | BEFREE |
C0853879 | Invasive carcinoma of breast | disease | BEFREE |
C0858252 | Breast adenocarcinoma | disease | CGI |
C0877165 | Short phalanx of finger | phenotype | HPO |
C0877373 | Advanced cancer | phenotype | BEFREE |
C0917816 | Mental deficiency | disease | HPO |
C0920646 | Ischemia of kidney | disease | BEFREE |
C0948740 | Hypoplasia of the pituitary gland | disease | HPO |
C0973461 | Dysphasia | disease | HPO |
C1140680 | Malignant neoplasm of ovary | disease | BEFREE |
C1168401 | Squamous cell carcinoma of the head and neck | disease | BEFREE |
C1257931 | Mammary Neoplasms, Human | group | CTD_human |
C1261473 | Sarcoma | group | BEFREE |
C1266158 | Nongerminomatous Germ Cell Tumor | disease | BEFREE |
C1269683 | Major Depressive Disorder | disease | BEFREE;PSYGENET |
C1292758 | Precursor T-cell lymphoblastic lymphoma | disease | BEFREE |
C1292769 | Precursor B-cell lymphoblastic leukemia | disease | BEFREE |
C1292778 | Chronic myeloproliferative disorder | disease | BEFREE |
C1301359 | Precursor T cell lymphoblastic leukemia/lymphoblastic lymphoma | disease | BEFREE |
C1302790 | Congenital malformation syndrome | group | BEFREE |
C1305420 | Prominent ear | phenotype | HPO |
C1306459 | Primary malignant neoplasm | group | BEFREE |
C1306460 | Primary malignant neoplasm of lung | disease | BEFREE |
C1306759 | Eosinophilic disorder | group | BEFREE |
C1317785 | Tooth size discrepancy | phenotype | HPO |
C1332206 | Adult Lymphoma | disease | BEFREE |
C1332977 | Childhood Leukemia | disease | BEFREE |
C1332979 | Childhood Lymphoma | disease | BEFREE |
C1333286 | Diencephalic Neoplasm | disease | BEFREE |
C1334274 | Invasive Carcinoma | phenotype | BEFREE |
C1335302 | Pancreatic Ductal Adenocarcinoma | disease | BEFREE |
C1335729 | Refractory Neoplasm | disease | BEFREE |
C1336733 | Thalamic Neoplasm | disease | BEFREE |
C1368871 | Pediatric Neoplasm | group | BEFREE |
C1386048 | Intrauterine retardation | phenotype | HPO |
C1387005 | Penis agenesis | disease | BEFREE |
C1390474 | Increased susceptibility to fractures | phenotype | HPO |
C1403035 | Subcutaneous lipoma | disease | HPO |
C1458155 | Mammary Neoplasms | group | BEFREE;CTD_human;LHGDN |
C1510586 | Autism Spectrum Disorders | disease | GWASCAT |
C1512409 | Hepatocarcinogenesis | disease | BEFREE |
C1512981 | Mammary Tumorigenesis | phenotype | BEFREE |
C1519670 | Tumor Angiogenesis | phenotype | BEFREE |
C1527249 | Colorectal Cancer | disease | BEFREE |
C1540912 | Hypereosinophilic syndrome | disease | BEFREE |
C1561643 | Chronic Kidney Diseases | group | BEFREE |
C1563719 | Kallmann Syndrome 1 | disease | BEFREE;CTD_human |
C1563720 | Kallmann Syndrome 2 (disorder) | disease | BEFREE;CLINVAR;CTD_human;UNIPROT |
C1619700 | RENAL ADYSPLASIA | disease | BEFREE |
C1621958 | Glioblastoma Multiforme | disease | BEFREE |
C1658953 | tumor vasculature | phenotype | BEFREE |
C1691215 | Penile hypospadias | disease | HPO |
C1704230 | Grade I Astrocytoma | disease | CTD_human |
C1704272 | Benign Prostatic Hyperplasia | disease | BEFREE |
C1704981 | Hyperparathyroidism-Jaw Tumor Syndrome | disease | BEFREE |
C1720275 | Gonadotropin releasing factor deficiency | disease | BEFREE |
C1762616 | Meningioma, benign, no ICD-O subtype | disease | BEFREE |
C1827524 | Wide spaced nipples | phenotype | HPO |
C1833340 | Synostotic Posterior Plagiocephaly | disease | CTD_human |
C1835452 | Hypoplastic ovary | phenotype | HPO |
C1836542 | Depressed nasal bridge | phenotype | HPO |
C1837084 | Short metacarpal | phenotype | HPO |
C1837218 | Cleft palate, isolated | disease | BEFREE;CTD_human |
C1837279 | Hypoplastic toenails | phenotype | HPO |
C1837760 | Prominent eyes | phenotype | HPO |
C1839326 | Abnormal form of the vertebral bodies | phenotype | HPO |
C1839764 | Broad flat nasal bridge | phenotype | HPO |
C1840077 | Anteverted nostril | phenotype | HPO |
C1842060 | Prominent supraorbital ridges | phenotype | HPO |
C1842229 | Broad metacarpals | phenotype | HPO |
C1842231 | Broad metatarsal | phenotype | HPO |
C1843108 | Short palm | phenotype | HPO |
C1843367 | Poor school performance | phenotype | HPO |
C1844704 | Platyspondyly | phenotype | HPO |
C1845146 | Holoprosencephaly, Ectrodactyly, and Bilateral Cleft Lip-Palate | disease | BEFREE;CLINVAR;ORPHANET;UNIPROT |
C1845147 | Hypoplasia of the frontal bone | phenotype | HPO |
C1846228 | Absence of pubertal development | phenotype | HPO |
C1846434 | Hypoplastic scapulae | phenotype | HPO |
C1848490 | Protruding eyes | phenotype | HPO |
C1848673 | Hypoplastic feet | phenotype | HPO |
C1849020 | Short metatarsal | phenotype | HPO |
C1849367 | Nasal bridge wide | phenotype | HPO |
C1850161 | Widened metatarsal shaft | phenotype | HPO |
C1853235 | Sclerocornea | disease | HPO |
C1853242 | Midface retrusion | phenotype | HPO |
C1854114 | Short nose | phenotype | HPO |
C1855185 | Broad phalanx | phenotype | HPO |
C1855285 | Protruding ear | phenotype | HPO |
C1855340 | Bowing of the long bones | phenotype | HPO |
C1855472 | Acute lymphoblastic leukemia with lymphomatous features | disease | CLINVAR |
C1855900 | HYPERTRICHOSIS, CONGENITAL GENERALIZED | disease | BEFREE |
C1856266 | Coronal craniosynostosis | disease | HPO |
C1856912 | Shortening of all middle phalanges of the fingers | phenotype | HPO |
C1857130 | Hypoplastic mandible condyle | phenotype | HPO |
C1857276 | Trichohepatoenteric Syndrome | disease | BEFREE |
C1857484 | Brachyturricephaly | phenotype | HPO |
C1857486 | Low-set, posteriorly rotated ears | phenotype | HPO |
C1858085 | Malar flattening | phenotype | HPO |
C1859592 | ATRICHIA WITH PAPULAR LESIONS | disease | BEFREE |
C1859775 | Anterior pituitary hypoplasia | phenotype | HPO |
C1860050 | Cloverleaf skull | phenotype | HPO |
C1860121 | Decreased testosterone in males | phenotype | HPO |
C1860816 | Preauricular skin tag | phenotype | HPO |
C1860819 | Metopic synostosis | disease | CTD_human |
C1861866 | Aplasia/Hypoplasia of the corpus callosum | phenotype | HPO |
C1862425 | Prominent globes | phenotype | HPO |
C1862863 | Sparse body hair | phenotype | HPO |
C1863360 | Radiohumeral synostosis of elbow | phenotype | HPO |
C1863363 | Cartilaginous trachea | phenotype | HPO |
C1864897 | Cognitive delay | phenotype | HPO |
C1865014 | Long philtrum | phenotype | HPO |
C1865244 | Shallow orbits | phenotype | HPO |
C1865992 | Short hallux | phenotype | HPO |
C1866227 | Somatic mosaicism | phenotype | HPO |
C1866241 | Broad foot | phenotype | HPO |
C1866260 | Peroxisome Biogenesis Disorder, Complementation Group H | disease | BEFREE |
C1866730 | Rhizomelia | disease | HPO |
C1867131 | Broad hallux | phenotype | HPO |
C1867616 | Dermoid choristoma of eye proper | disease | HPO |
C1867873 | Failure to thrive in infancy | phenotype | HPO |
C1868085 | Craniofacial hyperostosis | phenotype | HPO |
C1881254 | Inverted Squamous Cell Papilloma | disease | BEFREE |
C1882062 | Neoplastic disease | group | BEFREE |
C1961099 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | disease | BEFREE |
C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | disease | BEFREE |
C2145472 | Urothelial Carcinoma | disease | BEFREE |
C2227134 | mandibular excess (physical finding) | phenotype | HPO |
C2239176 | Liver carcinoma | disease | BEFREE;CLINVAR |
C2267233 | Neonatal Hypotonia | disease | HPO |
C2315100 | Pediatric failure to thrive | disease | HPO |
C2347979 | Rosette-forming glioneuronal tumor of the fourth ventricle | disease | CLINVAR |
C2364082 | Sense of smell impaired | phenotype | BEFREE;HPO |
C2673410 | Small midface | phenotype | HPO |
C2674432 | Reduced bone mineral density | phenotype | HPO |
C2675111 | Abnormality of the eyelashes | phenotype | HPO |
C2698204 | Metastatic Lobular Breast Carcinoma | disease | BEFREE |
C2699510 | Split-Hand/Foot Malformation | disease | BEFREE |
C2732838 | Neoplasm of skeletal system | group | HPO |
C2749463 | Aplasia/Hypoplasia of the radius | phenotype | HPO |
C2827362 | Myeloid and Lymphoid Neoplasms with FGFR1 Rearrangement | disease | BEFREE |
C2930865 | Ramer Ladda syndrome | disease | HPO |
C2930927 | Kallmann syndrome, type 3, recessive | disease | CTD_human |
C2931019 | Split hand foot deformity 1 | disease | BEFREE |
C2931150 | Synostotic Anterior Plagiocephaly | disease | CTD_human |
C2931822 | Nasopharyngeal carcinoma | disease | BEFREE |
C2931888 | Pfeiffer type acrocephalosyndactyly | disease | CTD_human |
C2939420 | Metastatic Neoplasm | phenotype | BEFREE |
C2945695 | Limb ischemia | disease | RGD |
C2973725 | Pulmonary arterial hypertension | disease | HPO |
C2981150 | Uranostaphyloschisis | disease | BEFREE;HPO |
C3150773 | CHROMOSOME 8p11 MYELOPROLIFERATIVE SYNDROME | disease | BEFREE;ORPHANET |
C3152182 | Anterior chamber anomalies | phenotype | HPO |
C3165106 | Infiltrating duct carcinoma of female breast | disease | UNIPROT |
C3179508 | Aplasia/Hypoplasia of the thumb | phenotype | HPO |
C3203102 | Idiopathic pulmonary arterial hypertension | disease | BEFREE;HPO |
C3278658 | Linear hyperpigmentation | phenotype | HPO |
C3278923 | Dilated ventricles (finding) | phenotype | HPO |
C3281200 | LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS | disease | BEFREE |
C3472608 | Micropapillary carcinoma | disease | BEFREE |
C3489396 | Hypogonadism, Isolated Hypogonadotropic | disease | BEFREE;HPO |
C3539878 | Triple Negative Breast Neoplasms | disease | BEFREE |
C3550546 | Depressed nasal root/bridge | phenotype | HPO |
C3642345 | Luminal A Breast Carcinoma | disease | BEFREE |
C3642346 | Luminal B Breast Carcinoma | disease | BEFREE |
C3665347 | Visual Impairment | phenotype | HPO |
C3714756 | Intellectual Disability | group | GENOMICS_ENGLAND;HPO |
C3814879 | Phosphaturic mesenchymal tumor, benign | disease | BEFREE |
C3887461 | Head and Neck Carcinoma | disease | CGI |
C3887650 | Adult Rickets | disease | BEFREE |
C3899503 | Congenital hypogonadotropic hypogonadism | disease | BEFREE |
C4016104 | HYPOGONADOTROPIC HYPOGONADISM 2 WITH ANOSMIA | phenotype | CLINVAR |
C4020771 | Neoplasia of the skeletal system | disease | HPO |
C4020855 | Respiratory function loss | phenotype | HPO |
C4020875 | Mental and motor retardation | phenotype | HPO |
C4020876 | Dull intelligence | phenotype | HPO |
C4020884 | Anxiety disease | disease | HPO |
C4021020 | Non-midline cleft lip | disease | HPO |
C4021107 | Non-obstructive azoospermia | disease | HPO |
C4021164 | Bicoronal synostosis | disease | HPO |
C4021343 | Broad hallux phalanx | phenotype | HPO |
C4021551 | Absence of secondary sex characteristics | phenotype | HPO |
C4021723 | Short middle phalanx of toe | phenotype | HPO |
C4021776 | Abnormality of the voice | phenotype | HPO |
C4021792 | Abnormality of the clavicle | phenotype | HPO |
C4021977 | Visceral angiomatosis | disease | HPO |
C4022003 | Erectile abnormalities | phenotype | HPO |
C4022180 | Lipomas of the central neryous system | disease | HPO |
C4022675 | Increased female libido | phenotype | HPO |
C4023018 | Subcortical cerebral atrophy | disease | HPO |
C4024202 | Reduced number of teeth | phenotype | HPO |
C4024589 | Aplasia/Hypoplasia of the mandible | phenotype | HPO |
C4024730 | Calcaneonavicular fusion | phenotype | HPO |
C4025069 | Multiple unerupted teeth | phenotype | HPO |
C4025569 | Eunuchoid habitus | phenotype | HPO |
C4025644 | Hypothalamic gonadotropin-releasing hormone deficiency | phenotype | HPO |
C4025750 | Abnormality of the nasopharynx | phenotype | HPO |
C4025821 | Anterior hypopituitarism | disease | HPO |
C4025835 | Abnormality of the nasolacrimal system | phenotype | HPO |
C4025901 | Abnormality of body height | phenotype | HPO |
C4049796 | Abnormality of cardiovascular system morphology | disease | HPO |
C4072823 | Broad cranium shape | phenotype | HPO |
C4072824 | Wide skull shape | phenotype | HPO |
C4072826 | Skin tag on the posterior cheek | phenotype | HPO |
C4082243 | Maxillary retrognathia | phenotype | HPO |
C4082304 | Oligodontia | disease | HPO;ORPHANET |
C4083050 | Tooth agenesis | phenotype | HPO |
C4083076 | Increased head circumference | phenotype | HPO |
C4255213 | Increased size of skull | phenotype | HPO |
C4280320 | Hypotrophic midface | phenotype | HPO |
C4280321 | Decreased projection of midface | phenotype | HPO |
C4280380 | Repeated speech | phenotype | HPO |
C4280483 | Thin bone of forehead | phenotype | HPO |
C4280484 | Hypotrophic frontal bones | phenotype | HPO |
C4280495 | Concave bridge of nose | phenotype | HPO |
C4280516 | Thick craniofacial bones | phenotype | HPO |
C4280517 | Enlargement of craniofacial bones | phenotype | HPO |
C4280518 | Hypertrophy of craniofacial bones | phenotype | HPO |
C4280564 | Cloverleaf cranium shape | phenotype | HPO |
C4280611 | Decreased size of teeth | phenotype | HPO |
C4280612 | Decreased width of tooth | phenotype | HPO |
C4280617 | Tooth mass arch size discrepancy | phenotype | HPO |
C4280618 | Inadequate arch length for tooth size | phenotype | HPO |
C4280619 | Missing more than six teeth | phenotype | HPO |
C4280625 | Decreased size of eyeball | phenotype | HPO |
C4280636 | Hypertrophy of supraorbital ridge | phenotype | HPO |
C4280637 | Hypertrophy of supraorbital margins | phenotype | HPO |
C4280638 | Hyperplasia of supraorbital ridge | phenotype | HPO |
C4280639 | Hyperplasia of supraorbital margins | phenotype | HPO |
C4280640 | Retrusion of upper jaw bones | phenotype | HPO |
C4280641 | Hypotrophic maxilla | phenotype | HPO |
C4280642 | Deficiency of upper jaw bones | phenotype | HPO |
C4280643 | Decreased projection of maxilla | phenotype | HPO |
C4280644 | Increased size of the mandible | phenotype | HPO |
C4280645 | Hypertrophy of lower jaw | phenotype | HPO |
C4280651 | Hypotrophic malar bone | phenotype | HPO |
C4280664 | Big calvaria | phenotype | HPO |
C4280665 | Wedge shaped head | disease | HPO |
C4280666 | Triangular head shape | disease | HPO |
C4280808 | Abnormally small eyeball | phenotype | HPO |
C4476523 | Decreased projection of lower jaw | phenotype | HPO |
C4476524 | Decreased projection of mandible | phenotype | HPO |
C4476525 | Retrusion of lower jaw | phenotype | HPO |
C4509816 | Squamous non-small cell lung cancer | disease | BEFREE |
C4531021 | Undergrowth | phenotype | HPO |
GO ID | GO Term | Evidence |
---|---|---|
GO:0004713 | protein tyrosine kinase activity | IDA |
GO:0004714 | transmembrane receptor protein tyrosine kinase activity | IBA |
GO:0005007 | fibroblast growth factor-activated receptor activity | IDA |
GO:0005007 | fibroblast growth factor-activated receptor activity | TAS |
GO:0005007 | fibroblast growth factor-activated receptor activity | IBA |
GO:0005515 | protein binding | IPI |
GO:0005524 | ATP binding | IEA |
GO:0008201 | heparin binding | IDA |
GO:0017134 | fibroblast growth factor binding | IDA |
GO:0017134 | fibroblast growth factor binding | IBA |
GO:0042169 | SH2 domain binding | IEA |
GO:0042802 | identical protein binding | IPI |
GO:0042803 | protein homodimerization activity | IPI |
GO:0090722 | receptor-receptor interaction | IDA |
GO ID | GO Term | Evidence |
---|---|---|
GO:0000122 | negative regulation of transcription by RNA polymerase II | IEA |
GO:0000165 | MAPK cascade | TAS |
GO:0001501 | skeletal system development | TAS |
GO:0001525 | angiogenesis | IEA |
GO:0001657 | ureteric bud development | IEA |
GO:0001701 | in utero embryonic development | IEA |
GO:0001759 | organ induction | IEA |
GO:0001764 | neuron migration | TAS |
GO:0002053 | positive regulation of mesenchymal cell proliferation | IEA |
GO:0002062 | chondrocyte differentiation | IEA |
GO:0006468 | protein phosphorylation | NAS |
GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | IBA |
GO:0007275 | multicellular organism development | IBA |
GO:0007605 | sensory perception of sound | IEA |
GO:0008284 | positive regulation of cell population proliferation | IMP |
GO:0008284 | positive regulation of cell population proliferation | IDA |
GO:0008284 | positive regulation of cell population proliferation | IGI |
GO:0008543 | fibroblast growth factor receptor signaling pathway | IPI |
GO:0008543 | fibroblast growth factor receptor signaling pathway | TAS |
GO:0008543 | fibroblast growth factor receptor signaling pathway | IDA |
GO:0008543 | fibroblast growth factor receptor signaling pathway | IGI |
GO:0010518 | positive regulation of phospholipase activity | TAS |
GO:0010863 | positive regulation of phospholipase C activity | IDA |
GO:0010966 | regulation of phosphate transport | IEA |
GO:0010976 | positive regulation of neuron projection development | IEA |
GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling | TAS |
GO:0016477 | cell migration | TAS |
GO:0018108 | peptidyl-tyrosine phosphorylation | IDA |
GO:0021847 | ventricular zone neuroblast division | IEA |
GO:0030326 | embryonic limb morphogenesis | IEA |
GO:0030901 | midbrain development | IEA |
GO:0033674 | positive regulation of kinase activity | IBA |
GO:0035607 | fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development | IEA |
GO:0042472 | inner ear morphogenesis | IEA |
GO:0042473 | outer ear morphogenesis | IEA |
GO:0042474 | middle ear morphogenesis | IEA |
GO:0043009 | chordate embryonic development | TAS |
GO:0043406 | positive regulation of MAP kinase activity | IDA |
GO:0043410 | positive regulation of MAPK cascade | IMP |
GO:0043536 | positive regulation of blood vessel endothelial cell migration | IGI |
GO:0045595 | regulation of cell differentiation | TAS |
GO:0045597 | positive regulation of cell differentiation | IBA |
GO:0045666 | positive regulation of neuron differentiation | IMP |
GO:0046777 | protein autophosphorylation | IDA |
GO:0048015 | phosphatidylinositol-mediated signaling | TAS |
GO:0048339 | paraxial mesoderm development | IEA |
GO:0048378 | regulation of lateral mesodermal cell fate specification | IEA |
GO:0048469 | cell maturation | IEA |
GO:0048705 | skeletal system morphogenesis | TAS |
GO:0048762 | mesenchymal cell differentiation | IEA |
GO:0051897 | positive regulation of protein kinase B signaling | TAS |
GO:0060045 | positive regulation of cardiac muscle cell proliferation | IEA |
GO:0060117 | auditory receptor cell development | IEA |
GO:0060445 | branching involved in salivary gland morphogenesis | IEA |
GO:0060484 | lung-associated mesenchyme development | IEA |
GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling | IEA |
GO:0070640 | vitamin D3 metabolic process | IEA |
GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway | IEA |
GO:0090272 | negative regulation of fibroblast growth factor production | IEA |
GO:1903465 | positive regulation of mitotic cell cycle DNA replication | IEA |
GO:1905564 | positive regulation of vascular endothelial cell proliferation | IGI |
GO:2000546 | positive regulation of endothelial cell chemotaxis to fibroblast growth factor | IDA |
GO:2000830 | positive regulation of parathyroid hormone secretion | IEA |
GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand | IEA |
GO ID | GO Term | Evidence |
---|---|---|
GO:0005576 | extracellular region | NAS |
GO:0005634 | nucleus | IEA |
GO:0005829 | cytosol | IEA |
GO:0005886 | plasma membrane | IDA |
GO:0005886 | plasma membrane | TAS |
GO:0005887 | integral component of plasma membrane | IBA |
GO:0016021 | integral component of membrane | NAS |
GO:0031410 | cytoplasmic vesicle | IEA |
GO:0043235 | receptor complex | IBA |
GO:0043235 | receptor complex | IDA |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-109704 | PI3K Cascade | TAS |
R-HSA-112399 | IRS-mediated signalling | TAS |
R-HSA-1226099 | Signaling by FGFR in disease | TAS |
R-HSA-1257604 | PIP3 activates AKT signaling | TAS |
R-HSA-1266738 | Developmental Biology | IEA |
R-HSA-1266738 | Developmental Biology | TAS |
R-HSA-1280215 | Cytokine Signaling in Immune system | TAS |
R-HSA-162582 | Signal Transduction | TAS |
R-HSA-1643685 | Disease | TAS |
R-HSA-168256 | Immune System | TAS |
R-HSA-1839120 | Signaling by FGFR1 amplification mutants | TAS |
R-HSA-1839122 | Signaling by activated point mutants of FGFR1 | TAS |
R-HSA-1839124 | FGFR1 mutant receptor activation | TAS |
R-HSA-190236 | Signaling by FGFR | TAS |
R-HSA-190242 | FGFR1 ligand binding and activation | TAS |
R-HSA-190370 | FGFR1b ligand binding and activation | TAS |
R-HSA-190373 | FGFR1c ligand binding and activation | TAS |
R-HSA-190374 | FGFR1c and Klotho ligand binding and activation | TAS |
R-HSA-199418 | Negative regulation of the PI3K/AKT network | TAS |
R-HSA-2219528 | PI3K/AKT Signaling in Cancer | TAS |
R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer | TAS |
R-HSA-2404192 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | TAS |
R-HSA-2428924 | IGF1R signaling cascade | TAS |
R-HSA-2428928 | IRS-related events triggered by IGF1R | TAS |
R-HSA-373760 | L1CAM interactions | TAS |
R-HSA-375165 | NCAM signaling for neurite out-growth | IEA |
R-HSA-422475 | Axon guidance | IEA |
R-HSA-422475 | Axon guidance | TAS |
R-HSA-445144 | Signal transduction by L1 | TAS |
R-HSA-5654219 | Phospholipase C-mediated cascade: FGFR1 | TAS |
R-HSA-5654687 | Downstream signaling of activated FGFR1 | TAS |
R-HSA-5654688 | SHC-mediated cascade:FGFR1 | TAS |
R-HSA-5654689 | PI-3K cascade:FGFR1 | TAS |
R-HSA-5654693 | FRS-mediated FGFR1 signaling | TAS |
R-HSA-5654726 | Negative regulation of FGFR1 signaling | TAS |
R-HSA-5654736 | Signaling by FGFR1 | TAS |
R-HSA-5655302 | Signaling by FGFR1 in disease | TAS |
R-HSA-5663202 | Diseases of signal transduction | TAS |
R-HSA-5673001 | RAF/MAP kinase cascade | TAS |
R-HSA-5683057 | MAPK family signaling cascades | TAS |
R-HSA-5684996 | MAPK1/MAPK3 signaling | TAS |
R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | TAS |
R-HSA-74751 | Insulin receptor signalling cascade | TAS |
R-HSA-74752 | Signaling by Insulin receptor | TAS |
R-HSA-8853336 | Signaling by plasma membrane FGFR1 fusions | TAS |
R-HSA-9006925 | Intracellular signaling by second messengers | TAS |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | TAS |
R-HSA-9607240 | FLT3 Signaling | TAS |
ID | Drug Name | Action | PubMed |
---|---|---|---|
D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of FGFR1 mRNA | 28628672 |
D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FGFR1 mRNA | 31009676 |
C548651 | 2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of FGFR1 mRNA | 19933214 |
C511295 | 2,2',4,4'-tetrabromodiphenyl ether | 2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of FGFR1 mRNA | 19095052 |
C070055 | 2,3',4,4',5-pentachlorobiphenyl | 2,3',4,4',5-pentachlorobiphenyl results in increased expression of FGFR1 mRNA | 31388691 |
C568950 | 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea | 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea results in decreased activity of FGFR1 protein | 21936542 |
C117011 | 3-(4-dimethylamino-benzylidenyl)-2-indolinone | 3-(4-dimethylamino-benzylidenyl)-2-indolinone results in decreased activity of FGFR1 protein | 15728459 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGFR1 mRNA | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGFR1 mRNA | 27188386 |
C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in decreased expression of FGFR1 mRNA | 12419474 |
C561052 | 5H-benzo(4,5)cyclohepta(1,2-b)pyridin-5-one | 5H-benzo(4,5)cyclohepta(1,2-b)pyridin-5-one results in decreased activity of FGFR1 protein | 21608528 |
C529910 | 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo(2,3-b)pyridin-5-yl)pyrrolo(2,1-f)(1,2,4)triazin-4-amine | 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo(2,3-b)pyridin-5-yl)pyrrolo(2,1-f)(1,2,4)triazin-4-amine results in decreased activity of FGFR1 protein | 20100840 |
C496492 | abrine | abrine results in increased expression of FGFR1 mRNA | 31054353 |
D000082 | Acetaminophen | Acetaminophen results in increased expression of FGFR1 mRNA | 21420995; 29067470; |
D000117 | Acetylglucosamine | Acetylglucosamine analog promotes the reaction [FGF2 protein binds to FGFR1 protein] | 12440867 |
D020106 | Acrylamide | Acrylamide analog promotes the reaction [FGF2 protein binds to FGFR1 protein] | 12440867 |
D020106 | Acrylamide | Acrylamide analog promotes the reaction [FGFR1 protein binds to FGFR1 protein] | 14733594 |
C029753 | aflatoxin B2 | aflatoxin B2 results in decreased methylation of FGFR1 intron | 30157460 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of FGFR1 mRNA | 16483693 |
D018501 | Antirheumatic Agents | Antirheumatic Agents results in increased expression of FGFR1 mRNA | 24449571 |
C463061 | AP20187 | AP20187 results in increased activity of FGFR1 protein mutant form | 12654294 |
D000077237 | Arsenic Trioxide | Arsenic Trioxide promotes the reaction [PD 173074 results in decreased expression of FGFR1 protein] | 27794399 |
D000077237 | Arsenic Trioxide | Arsenic Trioxide results in decreased expression of FGFR1 mRNA | 15761015; 19128835; |
D000077237 | Arsenic Trioxide | Arsenic Trioxide results in decreased expression of FGFR1 protein | 27794399 |
D000077237 | Arsenic Trioxide | Arsenic Trioxide results in decreased phosphorylation of FGFR1 protein mutant form | 17027752 |
D000077237 | Arsenic Trioxide | Arsenic Trioxide results in increased expression of FGFR1 mRNA | 17258074; 20458559; |
D000077237 | Arsenic Trioxide | FGFR1 protein results in decreased susceptibility to Arsenic Trioxide | 27794399 |
D000077237 | Arsenic Trioxide | PD 173074 promotes the reaction [Arsenic Trioxide results in decreased expression of FGFR1 protein] | 27794399 |
D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in decreased expression of FGFR1 mRNA | 23634900 |
D001397 | Azoxymethane | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FGFR1 mRNA | 29950665 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of FGFR1 mRNA | 22316170; 26238291; |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased mutagenesis of FGFR1 gene | 25435355 |
C543008 | bis(4-hydroxyphenyl)sulfone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of FGFR1 mRNA | 28628672 |
C006780 | bisphenol A | bisphenol A results in increased expression of FGFR1 mRNA | 20678512 |
C006780 | bisphenol A | bisphenol A results in increased expression of FGFR1 mRNA | 26063408 |
C006780 | bisphenol A | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of FGFR1 mRNA | 25607892 |
C006780 | bisphenol A | bisphenol A results in increased expression of FGFR1 mRNA | 25181051 |
C006780 | bisphenol A | bisphenol A results in increased methylation of FGFR1 gene | 28505145 |
D001786 | Blood Glucose | FGFR1 protein affects the abundance of Blood Glucose | 11130726 |
C038091 | butylparaben | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of FGFR1 mRNA | 25607892 |
D002104 | Cadmium | Cadmium results in increased expression of FGFR1 mRNA | 23369406 |
D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of FGFR1 mRNA | 12760830 |
D019256 | Cadmium Chloride | Cadmium Chloride results in decreased methylation of FGFR1 promoter | 22457795 |
D002117 | Calcitriol | Calcitriol results in decreased expression of FGFR1 mRNA | 26485663 |
D002117 | Calcitriol | [Calcium co-treated with Calcitriol] affects the expression of FGFR1 mRNA | 15913539 |
D002118 | Calcium | [Calcium co-treated with Calcitriol] affects the expression of FGFR1 mRNA | 15913539 |
D002211 | Capsaicin | Capsaicin results in decreased expression of FGFR1 protein | 14521749 |
D002220 | Carbamazepine | Carbamazepine affects the expression of FGFR1 mRNA | 24752500 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of FGFR1 mRNA | 17484886 |
D002746 | Chlorpromazine | Chlorpromazine analog results in decreased expression of FGFR1 mRNA | 15924885 |
D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FGFR1 gene | 20938992 |
D002945 | Cisplatin | Cisplatin promotes the reaction [jinfukang results in decreased expression of FGFR1 mRNA] | 27392435 |
D002945 | Cisplatin | Cisplatin results in decreased expression of FGFR1 mRNA | 27392435 |
D002945 | Cisplatin | jinfukang promotes the reaction [Cisplatin results in decreased expression of FGFR1 mRNA] | 27392435 |
D002945 | Cisplatin | Cisplatin results in increased expression of FGFR1 mRNA | 21151649 |
D003042 | Cocaine | Cocaine results in increased expression of FGFR1 mRNA | 16076954 |
D005576 | Colforsin | Colforsin results in increased expression of FGFR1 mRNA | 10320526 |
D003375 | Coumestrol | Coumestrol results in decreased expression of FGFR1 mRNA | 19167446 |
D000077547 | Crizotinib | [PD 173074 results in decreased activity of FGFR1 protein] inhibits the reaction [[Crizotinib results in decreased phosphorylation of MET protein] which results in increased expression of HGF protein] | 22683780 |
C029892 | cupric chloride | cupric chloride affects the expression of FGFR1 mRNA | 17211630 |
D003471 | Cuprizone | Cuprizone results in increased expression of FGFR1 mRNA | 26577399; 27523638; |
D003513 | Cycloheximide | Cycloheximide inhibits the reaction [Triiodothyronine results in increased expression of FGFR1 mRNA] | 12805413 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of FGFR1 mRNA | 25562108 |
D003609 | Dactinomycin | Dactinomycin inhibits the reaction [Triiodothyronine results in increased expression of FGFR1 mRNA] | 12805413 |
C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in decreased expression of FGFR1 mRNA | 23640034 |
D000077209 | Decitabine | Decitabine results in decreased expression of FGFR1 mRNA | 17785578 |
D000077209 | Decitabine | Decitabine results in increased expression of FGFR1 mRNA | 27915011 |
D003907 | Dexamethasone | Dexamethasone results in decreased expression of FGFR1 mRNA | 28453788 |
D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of FGFR1 mRNA | 28628672 |
D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FGFR1 mRNA | 31009676 |
D016264 | Dextran Sulfate | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FGFR1 mRNA | 29950665 |
D003913 | Dextroamphetamine | Dextroamphetamine results in decreased expression of FGFR1 mRNA | 12558987 |
D003976 | Diazinon | Diazinon results in decreased expression of FGFR1 mRNA | 17589599 |
D003976 | Diazinon | Diazinon results in increased expression of FGFR1 mRNA | 19130878 |
D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of FGFR1 mRNA | 21266533 |
D004008 | Diclofenac | Diclofenac affects the expression of FGFR1 mRNA | 24752500 |
D004026 | Dieldrin | Dieldrin results in increased expression of FGFR1 mRNA | 23041725 |
D004026 | Dieldrin | Dieldrin affects the expression of FGFR1 mRNA | 19130878 |
D004041 | Dietary Fats | Dietary Fats results in decreased expression of FGFR1 mRNA | 18042831 |
D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in decreased expression of FGFR1 mRNA | 31163220 |
D004052 | Diethylnitrosamine | FGFR1 protein results in increased susceptibility to Diethylnitrosamine | 19009564 |
D013196 | Dihydrotestosterone | Dihydrotestosterone results in decreased expression of FGFR1 mRNA | 17023530 |
C472511 | dimethylarsinous acid | dimethylarsinous acid results in decreased expression of FGFR1 mRNA | 16507463 |
D004147 | Dioxins | Dioxins affects the expression of FGFR1 mRNA | 20463971 |
D004237 | Diuron | Diuron results in decreased expression of FGFR1 mRNA | 25152437 |
C516138 | dorsomorphin | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGFR1 mRNA | 27188386 |
C516138 | dorsomorphin | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGFR1 mRNA | 27188386 |
D004317 | Doxorubicin | Doxorubicin results in decreased expression of FGFR1 mRNA | 29803840 |
D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal inhibits the reaction [FGF2 protein results in increased phosphorylation of FGFR1 protein] | 25856345 |
D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal results in decreased activity of FGFR1 protein | 25856345 |
D004610 | Ellagic Acid | Ellagic Acid results in decreased expression of FGFR1 mRNA | 12002526 |
C118739 | entinostat | entinostat results in increased expression of FGFR1 mRNA | 26272509 |
C118739 | entinostat | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGFR1 mRNA | 27188386 |
C038939 | enzacamene | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of FGFR1 mRNA | 25607892 |
D004958 | Estradiol | Estradiol results in decreased expression of FGFR1 mRNA | 19167446 |
C024552 | estrone benzoate | estrone benzoate inhibits the reaction [Progesterone results in decreased expression of FGFR1 mRNA alternative form] | 15120423 |
D000431 | Ethanol | Ethanol affects the expression of FGFR1 mRNA | 30319688 |
D000431 | Ethanol | Ethanol affects the splicing of FGFR1 mRNA | 30319688 |
D000431 | Ethanol | Ethanol results in increased expression of FGFR1 mRNA | 30319688 |
D000431 | Ethanol | Ethanol results in increased expression of FGFR1 protein | 29769550 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of FGFR1 mRNA | 23129252 |
C560274 | ethyl 8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carboxylate | ethyl 8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carboxylate analog inhibits the reaction [FGF2 protein results in increased phosphorylation of FGFR1 protein] | 21517068 |
C560274 | ethyl 8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carboxylate | ethyl 8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carboxylate analog results in decreased activity of FGFR1 protein | 21517068 |
C560274 | ethyl 8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carboxylate | ethyl 8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carboxylate inhibits the reaction [FGF2 protein results in increased phosphorylation of FGFR1 protein] | 21517068 |
C560274 | ethyl 8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carboxylate | ethyl 8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carboxylate results in decreased activity of FGFR1 protein | 21517068 |
C032773 | ethyl caffeate | ethyl caffeate affects the expression of FGFR1 protein | 24892518 |
C024565 | ethylene dichloride | ethylene dichloride results in decreased expression of FGFR1 mRNA | 28189721 |
C540355 | fenamidone | fenamidone results in increased expression of FGFR1 mRNA | 27029645 |
D017313 | Fenretinide | Fenretinide results in decreased expression of FGFR1 mRNA | 28973697 |
D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FGFR1 gene | 20938992 |
D005557 | Formaldehyde | Formaldehyde results in increased expression of FGFR1 mRNA | 23649840 |
C039281 | furan | furan results in increased expression of FGFR1 mRNA | 27387713 |
D005944 | Glucosamine | Glucosamine inhibits the reaction [IL1B results in decreased expression of FGFR1 mRNA] | 17109745 |
D005944 | Glucosamine | Glucosamine results in increased expression of FGFR1 mRNA | 17109745 |
D019812 | Heparan Sulfate Proteoglycans | [Heparan Sulfate Proteoglycans binds to FGF2 protein binds to FGFR1 protein] which binds to ANOS1 protein | 15548653 |
D019812 | Heparan Sulfate Proteoglycans | Heparan Sulfate Proteoglycans promotes the reaction [FGF1 protein binds to and results in increased activity of FGFR1 protein] | 15767480 |
D019812 | Heparan Sulfate Proteoglycans | Heparan Sulfate Proteoglycans affects the reaction [FGF1 protein binds to FGFR1 protein] | 10336501 |
D019812 | Heparan Sulfate Proteoglycans | Heparan Sulfate Proteoglycans affects the reaction [FGF2 protein binds to FGFR1 protein] | 10336501 |
D019812 | Heparan Sulfate Proteoglycans | Heparan Sulfate Proteoglycans affects the activity of FGFR1 protein | 15923150 |
D006493 | Heparin | Heparin promotes the reaction [FGF2 protein binds to FGFR1 protein] | 12440867 |
D006493 | Heparin | Heparin binds to FGFR1 protein binds to FGF2 protein | 15096041 |
D006493 | Heparin | Heparin promotes the reaction [FGFR1 protein binds to FGF1 protein] | 1379594 |
D006493 | Heparin | Heparin promotes the reaction [FGFR1 protein binds to FGF2 protein] | 1379594 |
D006493 | Heparin | Heparin promotes the reaction [FGF2 protein results in increased activity of FGFR1 protein] | 12799194 |
D006497 | Heparitin Sulfate | SULF1 protein inhibits the reaction [Heparitin Sulfate results in increased activity of FGFR1 protein] | 15051888 |
D006497 | Heparitin Sulfate | FGF1 protein binds to Heparitin Sulfate binds to FGFR1 protein | 12604602 |
D006497 | Heparitin Sulfate | Heparitin Sulfate analog results in increased activity of FGFR1 protein alternative form | 12460940 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide promotes the reaction [FGF2 protein binds to FGFR1 protein] | 8849686 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of FGFR1 mRNA | 12419474 |
D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of FGFR1 mRNA | 28628672 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of FGFR1 mRNA | 25613284 |
D015474 | Isotretinoin | Isotretinoin results in increased expression of FGFR1 mRNA | 20436886 |
C544151 | jinfukang | Cisplatin promotes the reaction [jinfukang results in decreased expression of FGFR1 mRNA] | 27392435 |
C544151 | jinfukang | jinfukang promotes the reaction [Cisplatin results in decreased expression of FGFR1 mRNA] | 27392435 |
C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of FGFR1 mRNA | 25961927 |
D007608 | Kainic Acid | Kainic Acid results in increased expression of FGFR1 mRNA | 7649223 |
C008261 | lead acetate | [lead acetate co-treated with zinc protoporphyrin] results in increased expression of FGFR1 mRNA | 22839698 |
D000077269 | Lenalidomide | Lenalidomide results in increased expression of FGFR1 mRNA | 30834740 |
D000077269 | Lenalidomide | Lenalidomide affects the expression of FGFR1 mRNA | 30834740 |
D008694 | Methamphetamine | Methamphetamine results in increased expression of FGFR1 mRNA | 29802913 |
D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FGFR1 gene | 20938992 |
D008727 | Methotrexate | FGFR1 protein affects the susceptibility to Methotrexate | 16217747 |
D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of FGFR1 mRNA | 20713471; 29554273; |
C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of FGFR1 mRNA | 28001369 |
C004925 | methylmercuric chloride | methylmercuric chloride affects the expression of FGFR1 mRNA | 21613230 |
D008770 | Methylnitrosourea | Methylnitrosourea results in increased expression of and affects the localization of FGFR1 protein | 15581186 |
C406082 | monomethylarsonous acid | monomethylarsonous acid results in increased expression of FGFR1 mRNA | 22108045 |
D009020 | Morphine | Morphine results in increased expression of FGFR1 mRNA | 15183518 |
D009287 | Naphthyridines | Naphthyridines analog results in decreased activity of FGFR1 protein | 16000000 |
C038541 | N-benzyloxycarbonylprolylprolinal | N-benzyloxycarbonylprolylprolinal results in decreased expression of FGFR1 mRNA | 21487212 |
D018817 | N-Methyl-3,4-methylenedioxyamphetamine | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of FGFR1 mRNA | 20188158 |
C118580 | octylmethoxycinnamate | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of FGFR1 mRNA | 25607892 |
D009844 | Oligosaccharides | Oligosaccharides promotes the reaction [FGF1 protein binds to and results in increased activity of FGFR1 protein] | 11714710 |
D009844 | Oligosaccharides | Oligosaccharides promotes the reaction [FGF1 protein binds to FGFR1 protein alternative form] | 9174673 |
C412603 | orantinib | orantinib results in decreased phosphorylation of and results in decreased activity of FGFR1 protein | 16144927 |
C412603 | orantinib | orantinib results in decreased activity of FGFR1 protein | 14760097; 15551349; 15788688; 16132614; 21517068; |
D000077150 | Oxaliplatin | [Oxaliplatin co-treated with Topotecan] results in increased expression of FGFR1 mRNA | 25729387 |
D000077150 | Oxaliplatin | Oxaliplatin results in increased expression of FGFR1 mRNA | 25729387 |
D000073878 | Palm Oil | Palm Oil results in decreased expression of FGFR1 mRNA | 18042831 |
D010261 | Paraoxon | Paraoxon results in decreased expression of FGFR1 mRNA | 24413757 |
D052638 | Particulate Matter | Particulate Matter affects the expression of FGFR1 mRNA | 30806761 |
D052638 | Particulate Matter | Particulate Matter results in increased expression of FGFR1 mRNA | 28412507 |
C107527 | PD 161570 | PD 161570 inhibits the reaction [FGFR1 protein results in increased phosphorylation of FGFR1 protein] | 12805413 |
C113399 | PD 166866 | PD 166866 results in decreased activity of FGFR1 protein | 15522930 |
C113399 | PD 166866 | PD 166866 inhibits the reaction [FGF1 protein results in increased expression of FGFR1 protein] | 15773903 |
C113399 | PD 166866 | PD 166866 inhibits the reaction [FGFR1 protein results in increased phosphorylation of FGFR1 protein] | 12805413 |
C113399 | PD 166866 | PD 166866 results in decreased activity of FGFR1 protein | 15121739; 15773903; |
C115711 | PD 173074 | Arsenic Trioxide promotes the reaction [PD 173074 results in decreased expression of FGFR1 protein] | 27794399 |
C115711 | PD 173074 | PD 173074 promotes the reaction [Arsenic Trioxide results in decreased expression of FGFR1 protein] | 27794399 |
C115711 | PD 173074 | PD 173074 results in decreased activity of FGFR1 protein | 22683780; 27794399; |
C115711 | PD 173074 | [PD 173074 results in decreased activity of FGFR1 protein] inhibits the reaction [[Crizotinib results in decreased phosphorylation of MET protein] which results in increased expression of HGF protein] | 22683780 |
C115711 | PD 173074 | PD 173074 results in decreased expression of FGFR1 protein | 27794399 |
D030421 | Peroxynitrous Acid | FGFR1 protein alternative form affects the susceptibility to Peroxynitrous Acid | 12573278 |
D010578 | Petroleum | Petroleum affects the expression of FGFR1 mRNA | 25208076 |
D010710 | Phosphates | FGFR1 protein alternative form promotes the reaction [FGF23 protein results in decreased uptake of Phosphates] | 27432882 |
C008922 | piperine | piperine binds to FGFR1 protein | 28341137 |
C006253 | pirinixic acid | pirinixic acid results in increased expression of FGFR1 mRNA | 12832660 |
C467566 | pomalidomide | pomalidomide results in increased expression of FGFR1 mRNA | 30834740 |
C467566 | pomalidomide | pomalidomide results in decreased expression of FGFR1 mRNA | 30834740 |
C545373 | ponatinib | ponatinib analog results in decreased activity of FGFR1 protein | 21561767 |
C545373 | ponatinib | ponatinib results in decreased activity of FGFR1 protein | 19878872; 21561767; |
C545373 | ponatinib | ponatinib results in decreased activity of FGFR1 protein mutant form | 19878872 |
C545373 | ponatinib | ponatinib results in decreased phosphorylation of FGFR1 protein mutant form | 21482694; 22875613; |
C545373 | ponatinib | ponatinib affects the activity of FGFR1 protein mutant form | 22301675 |
C545373 | ponatinib | ponatinib inhibits the reaction [FGFR1 protein mutant form results in increased phosphorylation of SRC protein] | 22781593 |
C545373 | ponatinib | ponatinib results in decreased activity of FGFR1 protein | 22238366 |
C545373 | ponatinib | ponatinib results in decreased phosphorylation of and results in decreased activity of FGFR1 protein mutant form | 22781593 |
D011374 | Progesterone | estrone benzoate inhibits the reaction [Progesterone results in decreased expression of FGFR1 mRNA alternative form] | 15120423 |
D011374 | Progesterone | Progesterone results in decreased expression of FGFR1 mRNA alternative form | 15120423 |
D011441 | Propylthiouracil | Propylthiouracil results in decreased expression of FGFR1 mRNA | 24780913 |
C513428 | pyrachlostrobin | pyrachlostrobin results in increased expression of FGFR1 mRNA | 27029645 |
D000077185 | Resveratrol | Resveratrol results in increased expression of FGFR1 mRNA | 12002526 |
D000077154 | Rosiglitazone | Rosiglitazone inhibits the reaction [Streptozocin results in decreased expression of FGFR1] | 24136780 |
C010327 | salinomycin | salinomycin results in decreased expression of FGFR1 mRNA | 19682730 |
C009277 | sodium arsenate | sodium arsenate results in increased expression of FGFR1 mRNA | 21795629 |
C017947 | sodium arsenite | sodium arsenite results in decreased expression of FGFR1 mRNA | 21281968 |
C017947 | sodium arsenite | sodium arsenite results in decreased expression of FGFR1 mRNA | 16876216 |
C016104 | sodium bichromate | sodium bichromate results in decreased expression of FGFR1 mRNA | 12760830 |
D013311 | Streptozocin | Rosiglitazone inhibits the reaction [Streptozocin results in decreased expression of FGFR1] | 24136780 |
D013311 | Streptozocin | Streptozocin results in decreased expression of FGFR1 | 24136780 |
C105686 | SU 5402 | SU 5402 results in decreased activity of FGFR1 protein | 16091734; 16154193; 16188231; |
C105686 | SU 5402 | SU 5402 results in decreased activity of FGFR1 protein mutant form | 16103074 |
C105686 | SU 5402 | SU 5402 results in decreased activity of FGFR1 protein | 12421715 |
C105686 | SU 5402 | SU 5402 results in increased expression of FGFR1 mRNA alternative form | 12421715 |
C105686 | SU 5402 | SU 5402 results in decreased activity of FGFR1 protein | 12704805; 15255957; 15298682; 15631803; 15936332; 16103074; 16326079; 17241745; |
D000077210 | Sunitinib | Sunitinib results in decreased expression of FGFR1 mRNA | 31533062 |
C061133 | tamibarotene | tamibarotene results in decreased expression of FGFR1 mRNA | 15498508 |
D013629 | Tamoxifen | FGFR1 protein results in decreased susceptibility to Tamoxifen | 20179196 |
D013654 | Taurine | Taurine results in decreased expression of FGFR1 mRNA | 16579726 |
D013739 | Testosterone | Testosterone results in increased expression of FGFR1 mRNA | 7536664 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of FGFR1 mRNA | 21632981 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of FGFR1 mRNA] | 15667827 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of FGFR1 mRNA | 19933214 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of FGFR1 mRNA | 17586704 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of FGFR1 mRNA | 25613284 |
D013792 | Thalidomide | Thalidomide results in decreased expression of FGFR1 mRNA | 30834740 |
D013792 | Thalidomide | Thalidomide affects the expression of FGFR1 mRNA | 30834740 |
C009495 | titanium dioxide | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FGFR1 mRNA | 29950665 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased expression of FGFR1 mRNA | 15289447 |
D024505 | Tocopherols | Tocopherols results in decreased expression of FGFR1 mRNA | 15144885 |
D019772 | Topotecan | [Oxaliplatin co-treated with Topotecan] results in increased expression of FGFR1 mRNA | 25729387 |
D019772 | Topotecan | Topotecan results in increased expression of FGFR1 mRNA | 25729387 |
D014204 | Trenbolone Acetate | Trenbolone Acetate results in increased expression of FGFR1 mRNA | 23314276 |
D014212 | Tretinoin | Tretinoin affects the expression of FGFR1 mRNA | 15498508 |
D014212 | Tretinoin | Tretinoin results in decreased expression of FGFR1 mRNA | 15498508 |
D014212 | Tretinoin | Tretinoin results in increased expression of FGFR1 mRNA | 16604517 |
D014212 | Tretinoin | Tretinoin results in increased expression of FGFR1 protein | 15389522 |
C011559 | tributyltin | tributyltin results in increased expression of FGFR1 mRNA | 29505797 |
D014284 | Triiodothyronine | Triiodothyronine results in increased expression of FGFR1 mRNA | 16150908 |
D014284 | Triiodothyronine | Cycloheximide inhibits the reaction [Triiodothyronine results in increased expression of FGFR1 mRNA] | 12805413 |
D014284 | Triiodothyronine | Dactinomycin inhibits the reaction [Triiodothyronine results in increased expression of FGFR1 mRNA] | 12805413 |
D014284 | Triiodothyronine | Triiodothyronine promotes the reaction [FGF2 protein promotes the reaction [FGFR1 protein results in increased phosphorylation of FGFR1 protein]] | 12805413 |
D014284 | Triiodothyronine | Triiodothyronine results in increased expression of FGFR1 mRNA | 12805413 |
D014284 | Triiodothyronine | Triiodothyronine results in increased expression of FGFR1 protein | 12805413 |
D014508 | Urea | Urea analog results in decreased activity of FGFR1 protein | 16000000 |
D014520 | Urethane | Urethane results in increased expression of FGFR1 mRNA | 28818685 |
D014635 | Valproic Acid | Valproic Acid affects the expression of FGFR1 mRNA | 25979313 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of FGFR1 mRNA | 23179753 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of FGFR1 mRNA | 29154799 |
D014635 | Valproic Acid | Valproic Acid results in increased methylation of FGFR1 gene | 29154799 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of FGFR1 mRNA | 19136453 |
D001335 | Vehicle Emissions | Vehicle Emissions results in increased methylation of FGFR1 gene | 25560391 |
D001335 | Vehicle Emissions | Vehicle Emissions results in decreased expression of FGFR1 mRNA | 19165385 |
C025643 | vinclozolin | vinclozolin results in increased expression of FGFR1 mRNA | 22615374 |
C029297 | vinylidene chloride | vinylidene chloride results in decreased expression of FGFR1 mRNA | 26682919 |
D000077337 | Vorinostat | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGFR1 mRNA | 27188386 |
D000077337 | Vorinostat | Vorinostat results in decreased expression of FGFR1 mRNA | 26272509 |
D014874 | Water Pollutants, Chemical | Water Pollutants, Chemical affects the expression of FGFR1 mRNA | 25208076 |
D014874 | Water Pollutants, Chemical | Water Pollutants, Chemical results in decreased expression of FGFR1 mRNA | 22899542 |
C017803 | zinc protoporphyrin | [lead acetate co-treated with zinc protoporphyrin] results in increased expression of FGFR1 mRNA | 22839698 |
Keyword ID | Keyword Term |
---|---|
KW-0002 | 3D-structure |
KW-0025 | Alternative splicing |
KW-0067 | ATP-binding |
KW-1003 | Cell membrane |
KW-0160 | Chromosomal rearrangement |
KW-0989 | Craniosynostosis |
KW-0963 | Cytoplasm |
KW-0968 | Cytoplasmic vesicle |
KW-0903 | Direct protein sequencing |
KW-0225 | Disease mutation |
KW-1015 | Disulfide bond |
KW-0242 | Dwarfism |
KW-0325 | Glycoprotein |
KW-0358 | Heparin-binding |
KW-0370 | Holoprosencephaly |
KW-1016 | Hypogonadotropic hypogonadism |
KW-0393 | Immunoglobulin domain |
KW-0956 | Kallmann syndrome |
KW-0418 | Kinase |
KW-0472 | Membrane |
KW-0991 | Mental retardation |
KW-0547 | Nucleotide-binding |
KW-0539 | Nucleus |
KW-0597 | Phosphoprotein |
KW-0621 | Polymorphism |
KW-0675 | Receptor |
KW-1185 | Reference proteome |
KW-0677 | Repeat |
KW-0732 | Signal |
KW-0804 | Transcription |
KW-0805 | Transcription regulation |
KW-0808 | Transferase |
KW-0812 | Transmembrane |
KW-1133 | Transmembrane helix |
KW-0829 | Tyrosine-protein kinase |
KW-0832 | Ubl conjugation |
InterPro ID | InterPro Term |
---|---|
IPR028174 | FGF_rcpt_1 |
IPR016248 | FGF_rcpt_fam |
IPR041159 | FGFR_TM |
IPR007110 | Ig-like_dom |
IPR036179 | Ig-like_dom_sf |
IPR013783 | Ig-like_fold |
IPR013098 | Ig_I-set |
IPR003599 | Ig_sub |
IPR003598 | Ig_sub2 |
IPR013151 | Immunoglobulin |
IPR011009 | Kinase-like_dom_sf |
IPR000719 | Prot_kinase_dom |
IPR017441 | Protein_kinase_ATP_BS |
IPR001245 | Ser-Thr/Tyr_kinase_cat_dom |
IPR008266 | Tyr_kinase_AS |
IPR020635 | Tyr_kinase_cat_dom |